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 Cellulose is the most abundant biopolymer in nature and is the major component of 
lignocellulosic biomass. It has potential to produce not only glucose but value–added products such as 
cellobiose and oligosaccharides. Typically, enzymatic hydrolysis of cellulose produces glucose and a 
small amount of cellobiose. Modification of cellulase solutions altered ratio of glucose to cellobiose 
produced. The addition of glucose oxidase, gluconolactone, or gluconic acid significantly increased the 
amount of cellobiose remaining at the end of cellulose hydrolysis. Addition of glucose oxidase resulted 
in cellobiose being 23.7% of the product sugars from pure cellulose and 14.1% from ligonocellulose 
(sugarcane bagasse). The presence of gluconolactone in the reaction mixture increased cellobiose to 31.3% 
of the sugars from cellulose and 15.8% from bagasse. The presence of gluconic acid changed the 
cellobiose to 21.9% of the sugars from cellulose and 13.2% from bagasse. In order to produce cellobio-
oligosaccharides, a dextransucrase from Leuconostoc mesenteroides B-512FMCM was employed to 
catalyze the transglycosylation reaction between cellobiose and sucrose. The major cellobio-
oligosaccharides were the trisaccharides, α-D-glucopyranosyl-(1→2)-cellobiose and α-D-
glucopyranosyl-(1→6)-cellobiose. Cellobio-oligosaccharides have valuable functional properties as 


































Cellobiose is a homoglucan disaccharide linked β-1,4 and is a repeating unit of cellulose, the 
most abundant biopolymer in nature. It has enormous biotechnological potential as a source of 
renewable products in food, cosmetic, and pharmaceutical industries. Enzymes, capable of breaking 
down cellobiose, are absent in humans. It is also poorly fermented by intestinal microbes, having an 
estimated a caloric value of 2 kcal/g (Nakamura, 2004). Therefore, cellobiose in its own right can be an 
effective sugar for diabetes and obesity control if it can be produced economically. The structural 
property due to the β-1,4 linkages gives the potential to synthesize novel compounds with specific 
functionalities by using glucosyl transferase analogous to the α-linked glucosides now available (Cote, 
2007). Cellobiose-acarbose analogues, produced by transglycosylation reactions are inhibitors of β-
glucosidase, whereas acarbose is not (Lee et al., 2001; Morales et al., 2001). Also, the fully or partially 
esterified cellobiose is a strong agent or thickener for water-immiscible liquid carriers and sustains its 
own shape with rigidity in cosmetic uses (Franklin et al., 2001). 
There is a lack of information on the economic cost and efficient production of cellobiose. Even 
though the oldest and easiest way to produce cellobiose is by acidic hydrolysis of cellulose, this process 
causes numerous problems including acid corrosion, neutralization requirements and side products 
causing difficulties in size control. Many of these problems can be avoided by using induced enzymatic 
hydrolysis of cellulose, which utilizes specific substrates under mild conditions, i.e. pH 4-7 and 
temperatures between 30-50°C (Homma et al., 1993). Cellulase, which hydrolyzes cellulose and consists 
of endo-β-glucanase (EC 3.2.1.4), exo-β-glucanase (EC 3.2.1.91), and β-glucosidase (EC 3.2.1.21) has 
been employed in this process (Henrissat et al., 1998). Cellobiose is released synergistically by endo- 
and exo-glucanase, and β-glucosidases. Cellobiose is then hydrolyzed to glucose by β-glucosidase. This 
enzyme is a potential target to control the product profile. Homma et al. (1993) removed β-glucosidase 
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from cellulase “complex” and produced cellobiose. However, they had to employ several processes, 
including affinity precipitation, pH control, and fractionation by gel chromatography to obtain a 
cellulase free of β-glucosidase. Tanaka and Oi (1985) produced 21 mg of cellobiose by polymerizing 30 
g of glucose using a β-glucosidase with a three-day incubation.  
Oxidized products of glucose, gluconolactone and gluconic acid, are known inhibitors of the 
cellulase system. Gluconolactone selectively inhibits the β-glucosidase activity in the cellulase system 
which includes endo-β-glucanase, exo-β-glucanase, and β-glucosidase (Holtzapple et al., 1990).  
1.2. LITERATURE REVIEW 
1.2.1. Cellulose 
 Cellulose constitutes the most abundant, renewable polymer resource in nature and is 
found primarily in plant cell walls. Except for cotton, present in a nearly pure state, cellulose fibers are 
embedded in a matrix with other structural polymers, primarily hemicellulose and lignin (Table 1.1). 
This limits the rate and extent of utilization of whole cellulose. Nevertheless, the use of cellulose as a 
precursor for the production of bio-ethanol and chemical production has been extensively studied 
because of its relatively low cost and plentiful supply (Lynd et al., 2002; Sun and Cheng, 2002).  
 Cellulose is composed of linear chains of β-(1→4)-D-glucopyranosyl units. Hydroxyl groups-
OH at the C-2, the C-3, and the C-6 positions within an anhydroglucose unit exhibit different polarities 
contributing to the formation of various inter- and intramolecular hydrogen bonds. All the hydroxyl 
groups are bonded equatorially in the glucopyranose ring, which produce hydrophilic sites parallel to the 
ring plane. The CH groups are bonded in the glucopyranose ring axially, which causes a hydrophobic 
site perpendicular to the ring (Kondo, 2005). Within the elementary fibrils of cellulose the arrangement 
of individual chains has been inferred from fitting of X-ray diffraction data to statistical models, 
calculating structure based on minimum conformational energy. Approximately 30 individual cellulose 
molecules assemble into larger units known as protofibrils, which are then packed into larger units  
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Table 1.1. Gross composition of some typical cellulose containing materialsa,b. 
 Composition (%) 
Source Cellulose Hemicellulose Lignin 
Bagasse 40 24-30 20-25 
Cotton 95 2 1 
Flax (retted) 71 21 2 
Hardwood stems 40-50 24-40 18-25 
Softwood stems 45-50 25-35 25-35 
Corn cobs 45 35 15 
Grasses 25-40 35-50 10-30 
Paper 85-99 0 0-15 
Wheat straw 30 50 15 



















called microfibrils, and these are in turn assembled into the familiar cellulose fibers. Cellulose 
microfibrils have regions of crystalline structure and both hydrophilic and hydrophobic regions due to 
the equatorially bonded HO-groups and axially bonded HC-groups (Sundari et al., 1991; Figure 1.1). 
Cellulose chains form numerous intra- and intermolecular hydrogen bonds, accounting for the formation 
of rigid and insoluble microfibrils. Adjacent sheets overlie one another and are held together by weak 
intersheet van der Waals forces. Strong inter- and intramolecular O-H···O bonds allow chains to co-
crystallize shortly after biosynthesis. Highly crystalline microfibrils held together by hydrogen bonds, 
hydrophobic interactions and van der Waals forces (Brown, Jr. and Saxena, 2000). The chains are 
oriented in parallel and form highly ordered crystalline domains interspersed by more disordered, 
amorphous regions (Béguin, 1994). The hydroxyl groups at the ends of each cellulose chain have 
different chemical properties. The number one carbon on the end of a cellulose chain contains an 
aldehyde hydrate group with reducing activity. On the terminal end of a cellulose chain, the number four 
carbon is an alcoholic hydroxyl with non-reducing activity. 
The packed chains are held together by both intrachain and interchain hydrogen bonds. Their 
effect over the many residues in the elementary fibril is considerable (Pizzi and Eaton, 1985). The 
crystalline nature of cellulose implies a structural order in which all of the atoms are fixed in discrete 
positions with respect to one another. Such feature stiffens individual microfibrils which are sufficiently 
tight to prevent penetration by even water, let alone enzymes (Lynd et al., 2002). Naturally occurring 
cellulose fibers are not pure crystalline, and the degree of departure from crystallinity varies. In addition 
to crystalline and amorphous regions, cellulose fibers contain various types of irregularities such as 
twists in the microfibrils, or voids such as surface micropores, large pits, and capillaries (Blouin et al., 
1970; Cowling, 1975). Degree of crystallization in cellulose varies among species. As crystallinity 



















1.2.2. Cellulase  
 Cellulase is a family of enzymes which hydrolyze cellulose (Emert et al., 1974). Cellulase can 
be used to hydrolyze cellulosic materials to sugars, which in turn can be fermented to bio-ethanol or 
used for other bio-based products (Cherry and Fidantsef, 2003). They are commercially used in the 
textile industry for cotton softening and denim finishing, the detergent market, the food industry for 
mashing, the pulp and paper industries for deinking, drainage improvement, and fiber modification 
(Cherry and Fidantsef, 2003; Kirk et al., 2002). Most cellulases are produced by fungi although there are 
some bacterial sources. The most well known cellulolytic fungi capable of utilizing cellulose as the 
primary carbon source are Sclerotium rolfsill, Phanerochaete chrysosporium, Trichoderma reesei, and 
species of Aspergillus, Penicillium, and Schizophyllum. Most commercial cellulase preparations include 
a β-glucosidase and are produced from either Trichoderma and/or Aspergillus species (Cherry and 
Fidansef, 2003).  
1.2.2.1. Classification of Cellulases 
 Cellulases are classified based on catalytic properties. A typical cellulosic enzyme system 
contains three major enzymes (Henrissat et al., 1998):  
(1) Exo-1,4-β-D-glucanase (EC 3.2.1.91; cellobiohydrolase), which cleaves cellobiose units from the 
end of cellulose chains. This class also includes the less common exo-1,4-β-D-glucan hydrolases 
(EC 3.2.1.74), which liberate D-glucose from the terminal ends of the cellulose chain. 
(2) Endo-1,4-β-D-glucanases (EC 3.2.1.4; EG), which hydrolyze internal β-1,4-glucosidic bonds 
randomly in the cellulose chain. 
(3) 1,4-β-D-glucosidases (EC 3.2.1.21), which hydrolyzes cellobiose to glucose and also cleaves off 




1.2.2.2. Cellulase Mechanism  
Generally cellulase has been found to have a modular structure that includes both catalytic and 
carbohydrate-binding modules (CBMs). The CBM binds to the cellulose surface, facilitating cellulose 
hydrolysis by bringing the catalytic domain to the proximal substrate, insoluble cellulose. CBMs are 
necessary for the initiation and functioning of exoglucanases. Din et al. (1994) revised the original 
model of cellulose degradation, which was proposed by Reese et al. (1950), adding a non-catalytic role 
for CBMs in cellulose hydrolysis. They reported that the “sloughing off” of cellulose fragments from 
cellulosic surfaces enhances cellulose hydrolysis. Cellulase systems present higher collective activity 
than the sum of the activities of individual enzymes, a phenomenon known as synergism (Figure 1.2). 
Synergism is divided to four forms: (1) endo-exo synergy between endoglucanases and exoglucanases, 
(2) exo-exo synergy between exoglucanases processing from the reducing and non-reducing ends of 
cellulose chains, (3) synergy between exoglucanases and β-glucosidases that remove cellobiose (and 
cellodextrins) as end products of the first two enzymes, and (4) intramolecular synergy between catalytic 
domains and CBMs (Din et al., 1994; Driskill et al., 1999; Lynd et al., 2002). Cellulase systems are not 
agglomerate enzymes representing the three enzyme groups such as endo-, exoglucanases and β-
glucosidases, with/without CBMs, but enzymes that act in a coordinated manner to efficiently hydrolyze 
cellulose (Tomme et al., 1995). Cellulolytic filamentous fungi such as the aerobic filamentous fungi 
Trichoderma reesei and Humicola insolens, and actinomycete bacteria are capable of penetrating 
cellulosic substrates with hyphal extensions, presenting their cellulase systems in confined cavities 
within cellulosic particles (Eriksson, 1990). The production of “free” cellulases, with or without CBMs, 
may be enough for the efficient hydrolysis of cellulose under these conditions. The best defined 
cellulase system is that of T. reesei, initially called T. viride (Lynd et al., 2002). The cellulase system 
from T. reesei includes at least two exoglucanases (CBHI and CBHII), five endoglucanases (EGI, EGII,  
 
















EGIII, EGIV, and EGV), and two β-glucosidases (BGLI and BGLII).  
1.2.2.3. Enzymatic Hydrolysis of Lignocellulosic Material 
 The hydrolysis of lignocellulosic material by cellulase is an expensive step accounting for 
approximately 30% of the total cost of bio-refinery due to the enzyme cost. Cellulase loading should be 
minimized but this increases the time required to complete the hydrolysis. The performance of cellulase 
in a bio-processing step on lignocellulosic material depends on a number of factors such as the presence 
and structure of lignin, temperature, pH, and substrate concentration. The use of slurry from a pretreated 
lignocellulosic material causes more problems than a pure cellulose. There is a lower substrate 
concentration because of the presence of other components (Gregg and Saddler, 1995). The enzyme 
performance is significantly reduced by end product inhibition and by sugars, and other degradation 
products produced during the pretreatment. To overcome some of these problems a washing step may be 
employed (Tenborg et al., 2001a; Tenborg et al., 2001b). The continuous removal of sugars has been 
tested using ultrafiltration (Ishihara et al., 1991; Gan et al., 2002). Similarly, a strategy to recycle the 
cellulases using ultrafiltration after hydrolysis has been investigated in order to reduce the cost of 
lignocellulose hydrolysis (Singh et al., 1991; Ramos et al., 1995).  
1.2.2.4. Cellulase Inhibition  
 Any process utilizing cellulase enzymes must deal with end-product inhibition. Quantitative 
research has been performed to elucidate the mechanisms of end-product inhibition in the cellulase 
systems (Philippidis et al., 1993; Xiao et al., 2004). However, the types of inhibition presented by 
cellulases are not straightforward (Holtzapple, 1990). Although most studies have shown that end 
products of cellulase systems generally cause competitive inhibition, some cellulases are 
noncompetitively or uncompetitively inhibited. This may be because the cellulase system includes multi-
enzyme components, moreover, they act synergistically.  
11 
 
Xiao et al. (2004) investigated the inhibitory effects of sugars; glucose, mannose, galactose, and 
xylose on both cellulase and β-glucosidase. Glucose supplementation of 20 g/L produced 53% inhibition 
of β-glucosidase at a cellobiose concentration of 20 g/L. However, cellulase activity produced a higher 
degree of inhibition than glucose supplementation on β-glucosidase. Simple sugars such as galactose, 
mannose, and xylose did not inhibit β-glucosidase at concentrations up to 100 g/L, whereas, these sugars 
have significant inhibitory effects on cellulase activity (Xiao et al., 2004). Previously researchers had 
reported that the addition of these sugars at more than 10 g/L was inhibitory to β-glucosidase (Saha et al., 
1994; Yun et al., 2001). 
Bezerra and Dias (2005) described an inhibitory effect of ethanol and cellobiose on both 
cellulase and purified exoglucanase Cel7A from T. reesei. Ethanol inhibited a crude cellulase in a 
noncompetitive manner at a lower concentration than on exoglucanase Cel7A, where it was a 
competitive inhibitor. Adsorption of cellulases to cellulose, especially cellobiohydrolases, is interferred 
with ethanol. Ethanol also modifies the cooperative effect between cellobiohydrolases and 
endoglucanases (Caldini et al., 1994). Cellobiose is a strong competitive inhibitor of exoglucanase 
Cel7A and a noncompetitive inhibitor of crude cellulase. Cellobiose inhibition is stronger than ethanol 
inhibition both for crude cellulases and exoglucanase Cel7A.  
Holtzapple et al. (1990) reported that glucose, cellobiose and the solvents-ethanol, acetone and 
butanol were noncompetitive inhibitors and δ-gluconolactone was a mixed inhibitor of cellulase from T. 
reesei.  
1.2.3. Cellobiose 
 Cellobiose is a glucan disaccharide linked β-1,4 and is a repeating unit of cellulose. It has 
enormous biotechnological potential as a renewable product for use in food, cosmetic, and 
pharmaceutical industries. Enzymes, capable of breaking down cellobiose, are absent in the human small 
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intestine. Nakamura (2004) confirmed that cellobiose may be slowly hydrolyzed by intestinal lactase in 
an in vitro study with rat small intestinal brush border membrane vesicles. He also estimated cellobiose 
bioavailability using cellobiose tolerance tests and breath hydrogen excretion tests from 10 healthy 
young women and concluded that cellobiose was poorly hydrolyzed or fermented by intestinal microbes, 
estimating a caloric value of 2 kcal/g in humans.  In the prebiotic study of Sanz et al. (2005), cellobiose 
resulted in a higher PI (prebiotic index), indicating a relationship between changes in the “beneficial” 
and “undesirable” elements within the microflora, than a currently used prebiotic agent, 
fructooligosaccharides. Correspondently, Yamazaki and Ichiro (2007) demonstrated 
cellooligosaccharides containing over 70% cellobiose are metabolized by Bifidobacterium and lactic 
acid bacteria and are not utilized by Clostridum perfringen and could be used for pharmaceuticals and 
functional foods.  Moreover, cellobiose fermentation in human fecal slurry gave a much higher content 
of butyric acid which has been shown to have cancer-preventing properties (Calabresse et al., 1993; 
Riggs et al., 1977) than fructooligosaccharides (Sanz et al., 2005). Orally administered cellobiose 
reduced neural fat in the liver and total cholesterol, proposing use as potential drugs for prevention and 
treatment of life style-related disease along with cellooligosaccharides (Yamazaki and Ibuki, 2008). 
Cellobiose was also utilized for the production of lactic acid by Lactobacillus delbrueckii mutant (Adsul 
et al., 2007). 
  There are some reports on new types of oligomers containing cellobiose as a component 
produced by transglycosylation reactions (Lee et al., 2001; Morales et al., 2001). Acarbose analogues 
containing cellobiose were prepared by the reaction of acarbose and maltose catalyzed by a Bacillus 
stearothermophilus maltogenic amylase (Lee et al., 2001). Cellobiose-acarbose analogues showed 







glucopyranose using cellobiose as an acceptor in the reaction catalyzed by alternansucrase (EC 2.4.1.140) 
from Leuconostoc mesenteroides NRRL B-23192.  
In this study, we quantified the degree and determined the pattern of inhibition of the cellulase 
system by gluconolactone, gluconic acid, or glucose oxidase, and analyzed productivity of cellobiose 
using Box-Behnken design.  
1.3. MATERIALS A	D METHODS 
1.3.1. Substrates, Enzymes, and Chemicals 
AvicelTM Type PH 101 (FMC, Philadelphia, PA) was swollen with phosphoric acid by the 
method of Rignall et al. (2002) prior to evaluation for the production of cellobiose. Ammonia treated 
sugarcane bagasse was kindly obtained from Dr. G. DeQueiroz (Audubon Sugar Institute, LSU Ag 
Center). The treated bagasse contained 58.2% glucan calculated from cellulase digestibility based on 
glucose and cellobiose concentration obtained after 48 hour hydrolysis. This glucan concentration was 
taken to reflect the cellulose content of the ammonia treated bagasse. The cellulosic substrates- 
phosphoric acid swollen AvicelTM and ammonia treated sugarcane bagasse were moistened ten times 
with 200 mM sodium citrate buffer, pH 5.2 prior to hydrolysis. Cellobiose (Sigma-Aldrich, St. Louis, 
MO) was employed as the substrate for the β-glucosidase assay. Cellulase, containing the complete 
cellulase system of exo- and endo-glucanase and β-glucosidase, synthesized by a Trichoderma viride 
strain, and glucose oxidase were both purchased from Sigma-Aldrich (St. Louis, MO). The chemicals 
used as inhibitors, gluconolactone and gluconic acid were also from the same source (Sigma-Aldrich, St. 
Louis, MO).  
14 
 
1.3.2. Enzyme Activities 
Cellulase activity was determined as FPU (filter paper unit) according to a NREL procedure 
(NREL accessed June 6, 2005). The unit definition of glucose oxidase followed that of the manufacturer 
where a unit is the amount that oxidizes 1.0 µmole of β-D-glucose to D-gluconolactone and H2O2 in one 
min at pH 5.1 and 37oC. The β-glucosidase activity was determined using cellobiose as a substrate.  
1.3.3. Enzyme Hydrolysis 
For inhibition studies, one percent of phosphoric acid swollen AvicelTM was used as a substrate 
and 0.46 FPU/ml (45.8 FPU/g glucans) of cellulase was used with varying concentrations of inhibitors, 
0.1-10% gluconolactone, 0.1-5% gluconic acid, or 0.51-510 U/ml of glucose oxidase. The activity was 
measured after 30 minutes reaction to minimize end product interference of cellulase and β-glucosidase. 
Several experimental groups were tested to optimize cellobiose production. They are defined and their 
conditions described below in the section of a Box-Behnken experimental design. All studies were 
performed at 37°C and 150 rpm in 200 mM sodium citrate buffer, pH 5.2 containing 6 µg/mL of 
tetracycline and 3 µg/mL of cyclohexamide. 
1.3.4. Quantification of Sugars 
The concentrations of cellobiose and glucose were measured using high-performance liquid 
chromatograph (HPLC) equipped with a refractive index detector. An Aminex-HPX-87K column (Bio-
Rad Lab., Hercules, CA) was used with 0.01 M K2HPO4 as mobile phase. It was run at a constant rate of 
0.6 ml/min at 85°C.  
1.3.5. Box-Behnken Experimental Design 
A four-factor and three-level Box-Behnken design was applied for optimization of cellobiose 
production using Design Expert 7.13 software (Stat-Ease, Inc.). Several factors, the amount of cellulose, 
cellulase, each inhibitor and reaction time, were used to prepare each of the 29 formulations given in 
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Tables 1.2 and 1.3. The high, medium, and low levels were selected based on preliminary 
experimentation. Optimization was performed using a desirability function to obtain the levels of X1, X2, 
X3, and X4.  
The behavior of the system has been explained by the following quadratic model equation (Box 
and Behnken, 1960); 




2 + β12X1X2 + β13X1X3 + β14X1X4 + 
β23X2X3 + β24X2X4 + β34X3X4  
     where Y is predicted response, β0 intercept, β1, β2, β3, and β4 linear coefficient, β11, β22, β33, and β44 
squared coefficients and β12, β13, β14, β23, β24, and β34 interaction coefficients. A total of 29 experiments 
were necessary to determine the 15 coefficients of model. 
1.4. RESULTS A	D DISCUSSIO	 
1.4.1. Inhibition Study on a Cellulase System 
The inhibition patterns produced by glucose oxidase on cellulase and β-glucosidase activity 
were compared (Figure 1.3; Day et al., 2008). The inhibition pattern was similar for both celluase and β-
glucosidase. The addition of greater than 0.1275 U/ml glucose oxidase reduced both cellulase and β-
glucosidase activity. In the presence of 51 U/ml glucose oxidase, activity was 11% of the original for β-
glucosidase and 26% of the original for cellulase showing the saturation for the inhibitor, glucose 
oxidase. An oxidized product of glucose by glucose oxidase, gluconic acid (Duke et al., 1969; Singh and 
Kumar, 2007) showed similar inhibition patterns for both cellulase and β-glucosidase (Figure 1.4). At a 
concentration of 1.0% gluconic acid, a 78% decrease in cellulase activity and 90% decrease in β-
glucosidase activity were observed. Gluconolactone also produced equivalent degrees of inhibition on 
both cellulase and β-glucosidase activity (Figure 1.5). Both enzymes lost approximately 70% of their 
activity in the presence of 0.02% gluconolactone. Gluconolactone has been reported to be a selective β- 
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-1 0 1 
X1: Cellulose (%) 1 3 5 
X2: Cellulase (FPU) 0.2 5.1 10.0 
X3: Glucose oxidase (U/ml) 0.51 5.1 51 
 Gluconic acid (%) 0.5 5.25 10 
 Gluconolactone (%) 0.10 2.55 5.00 





















Table 1.3. Formulations for a Box-Behnken design.   
Run X1 X2 X3 X4 
1 -1 -1 0 0 
2 -1 0 -1 0 
3 -1 0 0 -1 
4 -1 0 0 1 
5 -1 0 1 0 
6 -1 1 0 0 
7 0 -1 -1 0 
8 0 -1 0 1 
9 0 -1 0 -1 
10 0 -1 1 0 
11 0 0 -1 -1 
12 0 0 -1 1 
13 0 0 0 0 
14 0 0 0 0 
15 0 0 0 0 
16 0 0 0 0 
17 0 0 0 0 
18 0 0 1 -1 
19 0 0 1 1 
20 0 1 -1 0 
21 0 1 0 -1 
22 0 1 0 1 
23 0 1 1 0 
24 1 -1 0 0 
25 1 0 -1 0 
26 1 0 0 1 
27 1 0 0 -1 
28 1 0 1 0 





Figure 1.3. Changes of relative activities of cellulase and β-glucosidase in the presence of glucose 
oxidase. Relative activity is the % of enzyme activity in the presence of the test concentration of glucose 
oxidase to the enzyme activity of the reaction in the absence of glucose oxidase. For the determination 
of β-glucosidase activity, 0.3% cellobiose was reacted with 0.46 FPU/ml cellulase in 200 mM sodium 
citrate buffer (pH 5.2) at 37°C, for 30 min. For the determination of cellulase activity, 1% phosphoric 
acid swollen AvicelTM was reacted with 0.46 FPU/ml cellulase in the presence of 0, 0.002, 0.008, 0.0319, 
















































Figure 1.4. Relative activity of cellulase and β-glucosidase in the presence of glucononic acid. 
Relative activity is the % of enzyme activity at test concentration of gluconic acid to the enzyme activity 
in the absence of gluconic acid. Inserted figure is the relative activity in the presence of gluconic acid 
between 0 and 0.10%. For the determination of β-glucosidase activity, 0.3% cellobiose was reacted with 
0.46 FPU/ml cellulase in 200 mM sodium citrate buffer (pH 5.2) at 37°C for 30 min. For the 
determination of cellulase activity, 1% phosphoric acid swollen AvicelTM was reacted with 0.46 FPU/ml 
cellulase in the addition of 0, 0.02, 0.04, 0.10, 1.0, and 5.0% gluconic acid in 200 mM sodium citrate 















Figure 1.5. Relative activities of cellulase and β-glucosidase in the presence of gluconolactone. 
Relative activity is the % of enzyme activity at test concentration of gluconolactone to the enzyme 
activity at 0% gluconolactone addition. For the determination of β-glucosidase activity, 0.3% cellobiose 
was reacted with 0.46 FPU/ml cellulase in 200 mM sodium citrate buffer (pH 5.2) at 37°C for 30 min. 
For the determination of cellulase activity, 1% phosphoric acid swollen AvicelTM was reacted with 0.46 
FPU/ml cellulase in the addition of 0, 0.02, 0.04, and 0.06% gluconolactone in 200 mM sodium citrate 







































glucosidase inhibitor among a cellulase syst
1990; Philippidis et al 1993). Philippidis et al
produced a 70% loss of β-glucosidase activity but left intact cellulase activity at 10 
60 g/L of cellulose. Less than 4% of 
presence of 7.5 g/L gluconolactone with 20 g/L of cellulose (Holtzapple et al
data suggested that an inhibitor such as glucose oxidase, gluconolactone, or gluconic acid selectively 
inhibit β-glucosidase in a cellulase system. It has potential that exoglucanase and endoglucanase in 
cellulase synergistically act on cellulose hydrolysis when uncoupled from the hydrolytic action of β
glucosidase to produce increased amounts of cellobiose in a relatively short time.
Gluconic acid and gluconolactone act as mixed inhibitors since the lines intersect in the lower 
left quadrant (Figure 1.6 and Figure 1.7). The 
concentration and 3.5 mg/ml at 1% gluconolactone concentration. 
others in that gluconolactone and gluconic acid
et al., 1990). Mixed-type inhibition is sometimes called noncompetitive inhibition. Mixed inhibition type 
is represented in the following equilibria
The mixed type inhibition interprets that the presence of in
dissociation constant for substrate (S) from 
However, kinetic studies of sugars and their analogues on cellulase enzymes have been debated 
because the inhibition mechanism is largely dependent
21 
em, although its cost negates industrial use (Holtzapple et al 
. (1993) reported that the presence of 3 g/L
g/L of cellobiose and 
β-glucosidase activity and 87% of cellulase activity remained in the 
., 1990).
 
Ki values were 2.35 mg/ml at 5% gluconic acid              
Our inhibition studies agree with 
 exhibit mixed inhibition (Dixon et al., 1979; Holtzapple 
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hibitor (I) on the enzyme changes the 
Ks to αKs (Segel, 1976).  
 on the source and concentration of enzymes, the 
 gluconolactone 







Figure 1.6. Lineweaver-Burk plots for gluconic acid. The reaction was performed with 1% 
phosphoric acid swollen AvicelTM, 0.46 FPU/ml cellulase, and 5% gluconic acid in 200 mM sodium 
citrate buffer (pH 5.2) at 37°C for 30 min. As control, the reaction condition was same above except for 
glucononic acid absence. The inhibition degree was calculated based on the released glucose amount 


















































Figure 1.7. Lineweaver-Burk plots for gluconolactone. The reaction was performed with 1% 
phosphoric acid swollen AvicelTM, 0.46 FPU/ml cellulase, and 1% gluconolactone in 200 mM sodium 
citrate buffer (pH 5.2) at 37°C for 30 min. As control, the reaction condition was same above except for 
gluconolactone absence. The inhibition degree was calculated based on the released glucose amount 












































conditions of hydrolysis, and even the method of analysis of products (Gusakov and Sinitsyn, 1992; 
Dekker, 1988; Montero and Romeu, 1992). 
1.4.2. Effects of Inhibitors on Hydrolysis of Cellulose 
Cellobiose concentration was monitored over the course of 38 hours during the hydrolysis of 
cellulose in the presence of glucose oxidase, gluconic acid, or gluconolactone at 37oC. A considerable 
increase in cellobiose in solution was observed with more than 0.51 U/ml loading of glucose oxidase 
(Figure 1.8). The concentration of cellobiose in solution increased with increasing glucose oxidase 
loading up to 12 hours. Saturation of the reaction with glucose oxidase seem to be somewhere around 51 
U/ml glucose oxidase. The highest concentration of cellobiose achieved was 1.93 mg/ml in 24 hour 
hydrolysis in the presence of 51 U/ml of glucose oxidase and it was eight times higher than when 
glucose oxidase was absent. This increase may result from the combined effect of decreased cellulase 
inhibition by the removal of glucose by oxidization or from β-glucosidase inhibition by gluconic acid, a 
product of glucose oxidase. Without glucose oxidase, the concentration of cellobiose was only 0.24 
mg/ml. A decrease in cellobiose in solution was observed after it reached its highest point in samples 
with glucose oxidase. This is why an increase in cellobiose in solution might inhibit exoglucanase and 
endoglucanase as a product inhibition (Xiao et al., 2004; Bezerra and Dias, 2005; Holtzapple et al., 
1990), resulting in interference of cellobiose release.  
The log increases in glucose oxidase concentrations in the cellulase hydrolysis mixture 
produced continuous increases in cellobiose concentrations in solution at 12 hour hydrolysis (Figure 1.9; 
Day et al., 2008). A large excess of glucose oxidase suppressed the production of cellobiose. High 
concentrations of glucose oxidase may interfere with the cellulase hydrolysis reactions obstructing the 
approach of the cellulase to cellulose. Glucose yields decreased rapidly with the addition of increased 





Figure 1.8. Impact of various glucose oxidase loadings on the production of cellobiose during 1% 
Avicel
TM
 hydrolysis. The percentage of cellobiose yield was calculated at released cellobiose 
concentration to 1% phosphoric acid swollen AvicelTM. The reaction was performed with 1% phosphoric 
acid swollen AvicelTM and 0.46 FPU/ml cellulase in the presence of 0, 0.51, 5.1, and 51 U/ml glucose 
oxidase in 200 mM sodium citrate buffer (pH 5.2) at 37°C. The cellobiose concentration was tested at 0, 






































Figure 1.9. Impact of various glucose oxidase loadings on the production of cellobiose and glucose 
during 1% Avicel
TM
 hydrolysis at 12 hour hydrolysis. The percentage of cellobiose yield was 
calculated at released cellobiose concentration to 1% phosphoric acid swollen AvicelTM. The reaction 
was performed with 1% phosphoric acid swollen AvicelTM and 0.46 FPU/ml cellulase in the presence of 





































Gluconic acid addition to the reaction mixtures produced an increase in cellobiose during 
cellulose hydrolysis (Figure 1.10). The addition of 5% or 10% gluconic acid gave a similar pattern of 
cellobiose yield increases. The highest yield of cellobiose was 2.97 mg/ml in the presence of 5% 
gluconic acid over a 38 hour hydrolysis. This was ten times higher than the control reaction mixture 
(without gluconic acid). 
There were large differences in the amount of cellobiose produced when gluconolactone was 
added to reaction mixtures containing 1% AvicelTM and 0.46 FPU/ml cellulase (Figure 1.11). The 
highest yield of cellobiose (3.06 mg/ml) was achieved after 24 hours of cellulose hydrolysis by 
supplementing with 1% gluconolactone. Excess gluconolactone (more than 1%) inhibited both 
cellobiose and glucose production. The addition of 0.1% gluconolactone was insufficient for consistent  
production of cellobiose, since cellobiose concentration decreased rapidly with time.   
1.4.3. Box-Behnken Experimental Design 
 Optimization of cellobiose production from cellulose by cellulase in the presence of each 
inhibitor was achieved by employing a Box-Behnken design. The response surface methodology (RSM) 
was used to study the effect of interaction among independent variables on the production of cellobiose. 
RSM has been used as an effective statistical technique in the optimization of several biotechnological 
processes. RSM evaluates the effects of more than two independent variables on the dependent factor 
using multiple regression and correlation analysis. It has some advantages-the reduced number of 
experimental runs required to generate sufficient information to accept a statistical result and faster 
research method than classical tests (Kim and Day, 2007; Gunawan et al., 2005; Jeong and Park, 2007). 
In order to estimate the cellobiose yield from cellulose by cellulase modification system, the estimative 
response model equations were as follow: 




Figure 1.10. Impact of gluconic acid concentration on the production of cellobiose during 1% 
Avicel
TM
 hydrolysis. The percentage of cellobiose yield was calculated at released cellobiose 
concentration to 1% phosphoric acid swollen AvicelTM. The reaction was performed with 1% phosphoric 
acid swollen AvicelTM and 0.46 FPU/ml cellulase in the presence of 0, 1, 5, and 10% gluconic acid in 
200 mM sodium citrate buffer (pH 5.2) at 37°C. The cellobiose concentration was tested at 0, 12, 24, 








































Figure 1.11. Impact of gluconolactone concentration on the production of cellobiose during 1% 
Avicel
TM
 hydrolysis. The percentage of cellobiose yield was calculated at released cellobiose 
concentration to 1% phosphoric acid swollen AvicelTM. The reaction was performed with 1% phosphoric 
acid swollen AvicelTM and 0.46 FPU/ml cellulase in the presence of 0, 0.1, 1.0, 5.0, and 10.0% 
gluconolactone in 200 mM sodium citrate buffer (pH 5.2) at 37°C. The cellobiose concentration was 
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2 for a glucose oxidase model; 
Y = -10.43 + 2.63X1 + 16.76X2 + 8.16X3 + 2.41X4 + 0.86 X1X2 – 0.77 X1X3 +0.38 X1X4 +0.75 X2X3 -




2 for a gluconic acid model; 
Y = -25.12 + 20.43X1 + 4.05X2 + 11.03X3 + 4.48X4 + 0.59 X1X2 + 0.25 X1X3 +0.05 X1X4 +0.97 X2X3 




2 for a gluconolactone model 
where Y is the response factor, relative cellobiose yield (%), X1, X2, X3, and X4 are the real 
values of the independent factors; cellulose concentration (%), cellulase concentration (FPU), inhibitor 
(U/ml for glucose oxidase and % for others), and reaction time (h). Table 1.4 presents the actual and 
predicted values of cellobiose production on the basis of the experimental design, and their valu
es agreed reasonably. The results were analyzed by multiple regression and the coefficients were 
tested for their significance through regression analysis. The coefficients were evaluated through 
regression analysis. For the glucose oxidase model, two linear coefficients of X1 and X3, and one  
quadratic coefficient, X1
2 were determined to be significant at p<0.05 (Table 1.5). The glucose oxidase 
model is highly significant as an evidence from Fmodel = 10.44 and a low probability value (<0.0001) in 
the analysis of variance of this model. A gluconic acid model showed that three linear coefficient of X1, 
X2, X3, one cross-product coefficient of X2X3 and two quadratic coefficients of X2
2 and X4
2 were 
determined to be significant (Table 1.6). The gluconic acid model is also highly significant as an 
evidence from Fmodel=7.38 and a low probability value (0.0003) in the analysis of variance of this model 
(Table 1.6). Also, the F value of 0.86 for the lack of fit demonstrates that it is not significant relative to 
the pure error according to our results of analysis of factors, because non-significant lack of fit is a good 
indication that the model fits the actual relationships of the reaction parameters within the selected 





2 have significant effects at p<0.05 for the prediction of the cellobiose pro-  
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Table 1.4. Relative observed and predicted cellobiose yield (%) in the presence of inhibitors for 3-level-
4-factor response surface analysis. 
 
 
X3: Glucose Oxidase X3: Gluconic Acid X3: Gluconolactone 
Run
a
 Observed Y Observed Y Predicted Y Predicted Y Predicted Y Predicted Y 
1 52.76 55.49 50.63 40.19 55.49 54.40 
2 44.37 46.89 45.44 50.51 46.89 52.99 
3 50.45 55.79 72.21 70.12 55.79 62.76 
4 69.96 67.59 48.24 49.96 67.59 56.89 
5 59.89 65.56 79.32 69.70 65.56 68.80 
6 64.12 66.17 47.27 42.42 66.17 57.55 
7 64.77 61.00 36.15 39.03 61.00 59.08 
8 52.84 53.93 41.24 35.16 53.93 51.40 
9 54.05 54.82 37.78 34.49 54.82 59.58 
10 69.06 63.39 62.42 30.76 63.39 54.05 
11 54.55 75.05 59.61 49.68 75.05 58.32 
12 71.04 52.56 70.98 61.44 52.56 58.97 
13 80.96 99.08 100.18 75.05 99.08 95.49 
14 79.44 99.00 70.87 75.05 99.00 95.49 
15 74.15 98.95 92.00 75.05 98.95 95.49 
16 80.96 96.49 82.85 75.05 96.49 95.49 
17 79.44 87.86 83.22 75.05 87.86 95.49 
18 100.53 87.46 82.56 67.92 87.46 80.69 
19 85.38 56.83 67.44 52.32 56.83 73.10 
20 66.39 50.16 11.20 23.20 50.16 50.51 
21 81.13 61.65 79.90 60.63 61.65 69.59 
22 79.75 70.91 66.35 47.19 70.91 70.82 
23 81.35 99.65 96.71 84.76 99.65 92.05 
24 79.71 47.86 50.15 34.27 47.86 56.10 
25 87.97 61.84 67.44 65.41 61.84 63.81 
26 89.94 89.06 80.93 68.47 89.06 72.55 
27 91.49 72.13 68.51 52.15 72.13 73.62 
28 96.01 85.43 98.40 55.34 85.43 84.51 
29 87.18 81.72 87.65 70.21 81.72 82.38 
aInformation is mentioned in Table 1.3. 
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Table 1.5. ANOVA for response surface for cellobiose production in the presence of glucose oxidase. 
Source Sum of squares DF Mean square F-value Probability >F
a,b
 
Model 19390.89 14 1385.06 10.44 < 0.0001 
X1 5288.50 1 5288.50 39.86 < 0.0001 
X2 10.30 1 10.30 0.08 0.7846 
X3 3012.57 1 3012.57 22.71 0.0003 
X4 27.26 1 27.26 0.21 0.6573 
X1X2 531.37 1 531.37 4.01 0.0651 
X1X3 492.43 1 492.43 3.71 0.0746 
X1X4 110.98 1 110.98 0.84 0.3759 
X2X3 259.87 1 259.87 1.96 0.1834 
X2X4 0.01 1 0.01 0.00 0.9944 
X3X4 213.02 1 213.02 1.61 0.2258 
X1
2
 2260.11 1 2260.11 17.04 0.0010 
X2
2
 187.95 1 187.95 1.42 0.2537 
X3
2
 584.03 1 584.03 4.40 0.0545 
X4
2
 274.69 1 274.69 2.07 0.1722 
Residual 1857.44 14 132.67 
Lack of fit 1825.83 10 182.58 23.11 0.0041 
Pure error 31.61 4 7.90 
Correlation total 21248.32 28 
aProbability>F, level of significance. 
bValues of “probability > F” less than 0.05 indicate model terms are significant. Values greater than 0.1 








Table 1.6. ANOVA for response surface for cellobiose production in the presence of gluconic acid. 
Source Sum of squares DF Mean square F-value Probability >F
a,b
 
Model 11242.33 14 803.02 7.38 0.0003 
X1 1369.47 1 1369.47 12.58 0.0032 
X2 1021.62 1 1021.62 9.39 0.0084 
X3 4747.16 1 4747.16 43.62 < 0.0001 
X4 110.57 1 110.57 1.02 0.3306 
X1X2 363.37 1 363.37 3.34 0.0891 
X1X3 2.13 1 2.13 0.02 0.8908 
X1X4 331.03 1 331.03 3.04 0.1031 
X2X3 1549.65 1 1549.65 14.24 0.0021 
X2X4 64.20 1 64.20 0.59 0.4552 
X3X4 175.45 1 175.45 1.61 0.2249 
X1
2
 252.79 1 252.79 2.32 0.1498 
X2
2
 4232.85 1 4232.85 38.89 < 0.0001 
X3
2
 475.05 1 475.05 4.37 0.0554 
X4
2
 502.13 1 502.13 4.61 0.0497 
Residual 1523.63 14 108.83 
Lack of fit 1040.17 10 104.02 0.86 0.6164 
Pure error 483.46 4 120.86 
Correlation total 12765.96 28 
aProbability > F, level of significance. 
bValues of “probability > F” less than 0.05 indicate model terms are significant. Values greater than 0.1 










duction (Table 1.7). The model coefficients and probability values showed that the gluconolactone 
model is highly significant, as evident from the F (Fmodel = 4.40) and a very low probability value 
(0.0045).  
 Figure 1.12 shows the response of surface plots representing the effect of four factors-the 
concentration of cellulose, cellulase, and glucose oxidase, reaction time and their reciprocal interactions 
with cellobiose yield by holding two of the factors constant at a middle level. Figure 1.12a shows the 
effects of different concentrations of cellulase and cellulose on cellobiose production with a constant 
reaction time (24 hours) and glucose oxidase concentration (25.75 U/ml). The maximal cellobiose 
production was attained using 5% cellulose and 10 FPU cellulase. The effects of different concentrations 
of glucose oxidase and cellulose on cellobiose production with 5.1 FPU cellulase and a 24 hour reaction 
time are shown in Figure 1.12b. Maximal cellobiose production was seen at a cellulose concentration 
between 4 and 5% and glucose oxidase loading between 25.76 and 38.38 U/ml. Figure 1.12c represents 
the relationship between different concentrations of cellulose and reaction times on the cellobiose 
production, at a fixed concentration of 5.1 FPU cellulase and 25.75 U glucose oxidase. Across the entire 
range of reaction times, maximal cellobiose production was obtained at concentrations of cellulose of 
between 4 and 5%. As shown in Figure 1.12d, cellobiose production was affected only slightly by 
cellulase concentrations, the highest cellobiose production was achieved using glucose oxidase loadings 
ranged from 25.75 to 38.36 U/ml with 3% cellulose and a 24 hour reaction time. The effects of cellulase 
concentrations and reaction times on cellobiose production are shown in Figure 1.12e. The cellobiose 
production was sensitive to cellulase concentrations and reaction times. The optimal yield was obtained 
at 5.1 FPU cellulase and a 24 hour reaction time. Figure 1.12f shows the effects of different glucose 
oxidase concentrations and reaction times on cellobiose production with the fixed concentrations of 
cellulose (3%) and cellulase (5.10 FPU). An increase in the amount of introduced glucose oxidase  
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Table 1.7. ANOVA for response surface for cellobiose production in the presence of gluconolactone. 
 




6957.93 14 497.00 4.40 0.0045 
X1 
540.87 1 540.87 4.79 0.0460 
X2 
739.78 1 739.78 6.55 0.0227 
X3 
1015.08 1 1015.08 8.99 0.0096 
X4 
21.42 1 21.42 0.19 0.6698 
X1X2 
134.24 1 134.24 1.19 0.2939 
X1X3 
6.06 1 6.06 0.05 0.8201 
X1X4 
 6.59  1 6.59 0.06 0.8126 
X2X3 
543.96 1 543.96 4.82 0.0455 
X2X4 
25.70 1 25.70 0.23 0.6406 
X3X4 
16.55 1 16.55 0.15 0.7075 
X1
2 
1396.45 1 1396.45 12.37 0.0034 
X2
2 
2151.64 1 2151.64 19.06 0.0006 
X3
2 
1152.24 1 1152.24 10.21 0.0065 
X4
2 
1343.47 1 1343.47 11.90 0.0039 
Residual 
1580.11 14 112.87   
Lack of fit 
1486.72 10 148.67 6.37 0.0447 
Pure error 
93.39 4 23.35   
Correlation total 
8538.05 28    
aProbability > F, level of significance. 
bValues of “probability > F” less than 0.05 indicate model terms are significant. Values greater than 0.1 
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Figure 1.12. Response surface plots illustrating the effect of varying concentrations of Avicel
TM
, 
cellulase, and glucose oxidase, and reaction time on their reciprocal interactions with cellobiose 
production. Other factors are held constant at 25.75 U glucose oxidase and 24 h reaction time (a); 5.10 
FPU cellulase and 24 h reaction time (b); 5.10 FPU cellulase and 25.75 U glucose oxidase (c); 3% 
AvicelTM and 24 h reaction time (d); 3% AvicelTM and 25.75 U glucose oxidase (e); 3% AvicelTM and 
5.10 FPU celluase (f). All reactions were performed in 200 mM sodium citrate buffer (pH 5.2) at 37°C 




resulted in a linear increase in cellobiose up to 38.38 U/ml glucose oxidase. As a result, optimal value of 
the selected factors were determined as follow: X1 (cellulose) = 4%, X2 (cellulase) = 8.2 FPU, X3 
(glucose oxidase) = 17.3U/ml, and X4 (reaction time) = 16 hours. 
Figure 13 elucidates the relationship between the independent and dependent variables in the 
gluconic acid model. The best results were shown in cellulase loading between 2.65 and 7.55 FPU, 
whereas the increase in cellulose concentration did not increase cellobiose yield at 5.25% gluconic acid 
and 24 hour reaction time (Figure 1.13a). The effects of different gluconic acid concentrations and 
cellulose on the production of cellobiose at 5.1 FPU cellulase and 24 hour reaction time are shown in 
Figure 1.13b. Both increases in the amount of gluconic acid and cellulose resulted in a linear increase in 
cellobiose yield. Maximal production was conducted using a high gluconic acid and cellulose 
concentration. Figure 1.13c represents the effects of different concentration of cellulose and reaction 
time on cellobiose production at 5.1 FPU cellulase and 5.25% gluconic acid. Increase in reaction time 
resulted in rapid decrease in cellobiose production whereas different concentrations of cellulose 
introduced did not largely change cellobiose production. Cellobiose production was affected more by the 
amount of cellulase loading than reaction time at 3% AvicelTM and 5.25% gluconic acid (Figure 1.13d). 
Within the entire range of cellulase amount and reaction time, the maximal cellobiose production was 
accomplished at cellulase amount between 5.10 and 7.55 FPU. As shown in Figure 1.13e, the high 
concentration of gluconic acid (7.65-10%) resulted in an increased cellobiose production with a lower 
reaction time (18 hours) at 3% cellulose and 5.10 FPU cellulase. Figure 1.13f shows the effects of 
different concentrations of gluconic acid and cellulase on cellobiose production with a constant reaction 
time (24 hours) and cellulose concentration (3%).  
The optimal yield was obtained at 5.1 FPU cellulase and high concentration of gluconic acid 





Design points above predicted value
Design points below predicted value
100.179
11.2019
X1 = A: Cellullose
X2 = B: Cellulase
Actual Factors
C: Gluconic acid = 5.25































X1 = A: Cellullose
X2 = C: Gluconic acid
Actual Factors
B: Cellulase = 5.10































X1 = A: Cellullose
X2 = D: Reaction time
Actual Factors
B: Cellulase = 5.10


























  A: Cellullose    D: Reaction time  
Design-Expert?Software
Cellobiose
Design points above predicted value
Design points below predicted value
100.179
11.2019
X1 = B: Cellulase
X2 = D: Reaction time
Actual Factors
A: Cellullose = 3.00































X1 = C: Gluconic acid
X2 = D: Reaction time
Actual Factors
A: Cellullose = 3.00


























  C: Gluconic acid    D: Reaction time  
Design-Expert?Software
Cellobiose
Design points above predicted value
Design points below predicted value
100.179
11.2019
X1 = B: Cellulase
X2 = C: Gluconic acid
Actual Factors
A: Cellullose = 3.00






























Figure 13. Response surface plots illustrating the effect of varying concentrations of Avicel
TM
, 
cellulase, and gluconic acid, and reaction time on their reciprocal interactions with cellobiose 
production. Other factors are held constant at 5.25% gluconic acid and 24 h reaction time (a); 5.10 FPU 
cellulase and 24 h reaction time (b); 5.10 FPU cellulase and 5.25% gluconic acid (c); 3% AvicelTM and 
5.25% gluconic acid (d); 3% AvicelTM and 5.10 FPU cellulase (e); 3% AvicelTM and 24 h reaction time 




X1 (cellulose) = 4%, X2 (cellulase) = 2.5 FPU, X3 (gluconic acid) = 9.5%, and X4 (reaction time) = 22 
hours. 
Figure 1.14 shows the relationship in the presence of gluconolactone between the independent 
and dependent variables elucidated using contour and response surface plots. The best results are 
restricted to AvicelTM concentration between 2 and 4%, cellulase loading between 2.55 and 7.55 FPU, 
gluconolactone concentration between 2.55 and 3.77, and reaction time between 18 and 30 hours. They 
present the narrowest ranges of values that generated the zone of high values of the desirability function. 
Finally, the optimal conditions for the production of cellobiose were determined as follow: X1 
(cellulose)=4%, X2 (cellulase)=7.6 FPU, X3 (gluconolactone)=3.9%, and X4 (reaction time) =25 hours. 
1.4.4. Production of Cellobiose from Lignocellulosic Biomass 
Cellobiose production was tested using the optimal conditions obtained from Box-Behnken 
design with phosphoric acid swollen AvicelTM and ammonia treated sugarcane bagasse as lignocellulosic 
biomass. The concentration of ammonia treated sugarcane bagasse was introduced with the same 
cellulose content into the reaction mixture. Cellobiose production of 9.48 mg/ml from phosphoric acid 
swollen AvicelTM and 9.84 mg/ml from ammonia treated sugarcane bagasse was observed in glucose 
oxidase mixtures whereas non-glucose oxidase reaction mixtures produced 1.2-1.3 mg/ml of cellobiose 
(Figure 1.15). Also, enzymatic conditions in the presence of gluconic acid showed increased cellobiose 
production of 8.76 mg/ml from phosphoric acid swollen AvicelTM and 9.24 mg/ml from ammonia treated 
sugarcane bagasse whereas non-gluconic acid added reaction mixtures produced 1.2-1.3 mg/ml of 
cellobiose (Figure 1.16). The enzymatic modification system with gluconolactone showed increased 
cellobiose production of 12.5 mg/ml from phosphoric acid swollen AvicelTM and 11.03 mg/ml from 
ammonia treated sugarcane bagasse whereas non-gluconolactone added reaction mixtures produced 1.2-
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Figure 1.14. Response surface plots illustrating the effect of varying concentrations of Avicel
TM
, 
cellulase, and gluconolactone, and reaction time on their reciprocal interactions with cellobiose 
production. Other factors are held constant at 2.55% gluconolactone and 24 h reaction time (a); 5.10 
FPU cellulase and 24 h reaction time (b); 3% AvicelTM and 24 h reaction time (c); 3% AvicelTM and 2.55% 
gluconolactone (d); 3% AvicelTM and 5.1 FPU cellulase (e); 5.1 FPU cellulase and 2.55% 
gluconolactone (f). All reactions were performed in 200 mM sodium citrate buffer (pH 5.2) at 37°C and 






Figure 1.15. Cellobiose production from cellulose using cellulase modification system with glucose 
oxidase. The production of cellobiose from 4% phosphoric acid swollen AvicelTM was determined with 
reaction mixtures containing 8.2 FPU cellulase and 17.3U glucose oxidase after 16 h hydrolysis. The 
production of cellobiose from 7% ammonia treated bagasse was evaluated with reaction mixtures 
containing 8.2 FPU cellulase and 17.3U glucose oxidase after 16 h hydrolysis. The control reaction 
mixtures contained the same formulations except for glucose oxidase absence. All reaction mixture was 
performed in 200 mM sodium citrate buffer (pH 5.2) at 37°C and 150 rpm. Error bars show the standard 





































Figure 1.16. Cellobiose production from cellulose using cellulase modification system with gluconic 
acid. The production of cellobiose from 4% phosphoric acid swollen AvicelTM was determined with 
reaction mixtures containing 2.5 FPU cellulase and 9.5% gluconic acid after 22 h hydrolysis. The 
production of cellobiose from 7% ammonia treated bagasse was evaluated with reaction mixtures 
containing 2.5 FPU cellulase and 9.5% gluconic acid after 25 h hydrolysis. The control reaction 
mixtures contained the same formulations except for gluconic acid absence. All reaction mixture was 
performed in 200 mM sodium citrate buffer (pH 5.2) at 37°C and 150 rpm. Error bars show the standard 





































Figure 1.17. Cellobiose production from cellulose using cellulase modification system with 
gluconolactone. The production of cellobiose from 4% phosphoric acid swollen AvicelTM was 
determined with reaction mixtures containing 7.6 FPU cellulase and 3.9% gluconolactone after 25 h 
hydrolysis. The production of cellobiose from 7% ammonia treated bagasse was evaluated with reaction 
mixtures containing 7.6 FPU cellulase and 3.9% gluconolactone after 25 h hydrolysis. The control 
reaction mixtures contained the same formulations except for gluconolactone absence. All reaction 
mixture was performed in 200 mM sodium citrate buffer (pH 5.2) at 37°C and 150 rpm. Error bars show 






































its initial cellulose substrate was achieved with 4% substrate, 7.6 FPU cellulase, and 3.9% 
gluconolactone. Increasing cellobiose concentrations inhibited cellulase activity, blocking further 
increases in cellobiose production. Cellobiose has been known as a strong inhibitor of cellulase. 
Especially, Cel 7A which is one of the exoglucanases and the most abundant cellulase produced by T. 
reesei is inhibited by cellobiose (Gruno et al., 2004). Other researchers also agreed that cellobiose 
exhibits a great impact on cellulase activity (Gusakov and Sinitsyn, 1992; Holzapple et al., 1990; Xiao et 
al., 2004; Dekker, 1986). Holtzapple et al. (1990) hypothesized that the inhibitor binds to the active site 
as is seen in the relative values of the cellobiose and glucose binding constants regardless of the 
inhibition pattern. Also, they reported that the cellobiose binding constant was 3-14 times greater than  
the glucose binding constants because the cellulase active site binds β-1,4-linked glucose polymers, 
longer glucose polymers have more sites of attachment and hence a greater binding constant.  
Lignocellulose substrate-ammonia treated sugarcane bagasse produced less cellobiose than 
phosphoric acid swollen AvicelTM on the basis of yield (%) although it was superior to the control. The 
addition of glucose oxidase yielded 23.7% cellobiose from AvicelTM, but 11.48% of cellobiose from 
bagasse. The addition of gluconic acid yielded 21.9% cellobiose from AvicelTM, but 9.2% cellobiose 
from bagasse, and the addition of gluconolactone produced 31.3% cellobiose from AvicelTM and 11.0% 
cellobiose from bagasse. Lignocellulosic materials like sugarcane bagasse consist of rigid cellulose 
fibers embedded in a cross-linked matrix of lignin and hemicelluloses that bind the fibers. Even though 
it was pretreated with chemicals like ammonia, acids, and lime, it is still complex, and many undesired 
components-remnant lignin and hemicelluloses and phenolic compounds that might interfere with this 
inhibition system remain. Studies on the production of cellobiose have been reported by several 
researchers (Tanaka, 2000; Homma et al., 1993; Tanaka and Oi, 1985). Tanaka (2000) produced 3-3.5 g 
of cellobiose from 50 g of microcrystalline cellulose by their cellulase component, PEAK I during the 
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steady state from 6.8-24 days. According to Homma et al. (1993), using cellulase enzyme which had β-
glucosidase removed obtained 0.9 g of cellobiose from 46.6 g of cellulose after carrying out repeated 
batch reaction each for 20 hours three times for a total 60 hours. However, they should perform several 
enzyme preparations including affinity precipitation, pH control, and fractionation by gel 
chromatography before enzyme reaction for cellobiose production. Tanaka and Oi (1985) reported that 
21 mg of cellobiose was polymerized from 30 g of glucose by β-glucosidase in a three-day incubation. 
Compared with results from others (Tanaka, 2000; Homma et al., 1993; Tanaka and Oi, 1985), our 
enzymatic modification system, adding a β-glucosidase inhibitor to a cellulase hydrolysis reaction has 
potential to be an alternate model to produce a considerable amount of cellobiose. If there is a market for 
the material, it potentially could be a supplemental product for a biorefinery.  
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CHAPTER 2. CELLOBIO-OLIGOSACCHARIDE PRODUCTIO	 BY A DEXTRA	SUCRASE 























Oligosaccharides are carbohydrate polymers, generally of two to ten monomeric residues linked 
by O-glycosidic bonds (Staněk, 1965). Most commercial oligosaccharides were originally developed as 
sweeteners, but they are currently valued as soluble fibers, which decrease gastrointestinal transit time 
and moderate constipation and diarrhea. Oligosaccharides are considered to be a low calorie food, 
because they are resistant to attack by digestive enzymes in humans and animals and are not absorbed by 
the host (Farworth, 2001). Oligosaccharides may be produced through hydrolysis of polysaccharides, 
enzymatic synthesis, or extraction from naturally occurring sources. The major commercial 
oligosaccharides include cyclomaltodextrins, maltodextrins, fructooligosaccharides, 
galactooligosaccharides, and soy oligosaccharides (Eggleston and Côte, 2003).  
 Enzymatic production of oligosaccharides has many advantages over other methods, especially 
chemical methods (Park et al., 1998). Chemical reactions require complicated procedures for the specific 
protection of hydroxyl groups, whereas this is not necessary for enzymatic processes. An enzyme may 
transfer one or two hydroxyl groups with the transfer to one being preferred over the other. This limits 
the reaction steps, simplifies purification and may give higher yields of the desired oligomers. In most 
cases, the enzymatic synthesis of oligosaccharides has used transglycosylation reactions between a 
specific donor and a relatively large variety of structurally different acceptors. The configuration of the 
glycosidic bond produced is a function of the specificity of the transfer by the specific enzyme (Fu et al., 
1990; Robyt, 1995). Various oligosaccharides have been produced by enzymatic transfer reactions from 
glucansucrases (Fu et al., 1990; Robyt 1995), amylosucrases (Skov et al., 2001), cyclodextrin 
glucanosyltransferases (Vetter et al., 1992; Baek et al., 2000), and sialy transferases (Venot et al., 1994).  
Dextransucrase (EC 2.4.5.1) is a glucosyltransferase, which catalyses the transfer of D-
glucopyranosyl residues from sucrose to dextran (Monsan et al., 2001). It catalyzes synthesis of a 
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dextran containing 50% or more α-1,6 glucosidic bonds in the main chain. However, in the presence of 
an alternate efficient acceptor molecule, its action changes to produce oligosaccharides. 
Cellobiose is a disaccharide composed of two glucose molecules linked with a β-1,4 bond, 
produced during the enzymatic hydrolysis of cellulose. There are some reports on a new class of sugars, 
containing cellobiose as a component, produced by transglycosylation reactions (Lee et al., 2001; 
Morales et al., 2001). Acarbose analogues containing cellobiose were prepared by the reaction of 
acarbose and cellobiose with Bacillus stearothermophilus alpha maltogenic amylase (EC 3.2.1.133; Lee 
et al., 2001). Cellobiose-acarbose analogues show a potential for use as an inhibitor of β-glucosidase, 
whereas acarbose does not (Lee et al., 2001). Morales et al. (2001) produced oligosaccharides with 
branched chains, using cellobiose as an acceptor, in a reaction catalyzed by alternansucrase from 
Leuconostoc mesenteroides NRRL B-23192.  L. mesenteroides B512 FMCM produces an extracellular 
dextransucrase which synthesizes a dextran that has 95% α-(1→6) linear and 5% α-(1→3) branched 
linkages, and can transfer glucosyl units from sucrose onto an acceptor to produce oligosaccharides 
(Lindberg and Svensson, 1968). 
2.2. LITERATURE REVIEW 
2.2.1. Enzymatic Synthesis of Oligosaccharides 
 A wide variety of oligosaccharides have been synthesized by enzymatic transfer reactions 
between a segment of a specific donor and various acceptors (Park et al., 1998). The enzyme determines 
the specificity of the transfer and the configuration of glycosidic bond formed. The chemical structure of 
acceptor is very important in determining the position of transfer for glycosidic bond formation (Fu et al., 
1990; Robyt, 1995). Many oligosaccharides have been synthesized by enzymatic transfer reactions 
involving glucansucrases (Fu et al., 1990; Robyt 1995), alpha amylases (Tonozuka et al., 1994), 
amylosucrases (Skov et al., 2001), cyclodextrin glucanosyltransferases (Vetter et al., 1992; Baek et al., 
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2000), and sialy transferases (Venot et al., 1994). Tonozuka et al. (1994) reported a transglycosylation 
reaction by Thermoactinomyces vulgaris R-47 alpha-amylase. The alpha amylase primarily hydrolyzes 
α-(1→4)-linked glucose residues in the acceptor molecule. After all the α-(1→4)-linked glucose residues 
are hydrolyzed, the alpha amylase links glucose to the acceptor molecule by α-(1→3) and α-(1→6) 
glycosidic linkages. Maltogenic amylase from Bacillus stearothermophilus cleaves the first α-(1→4) 
glucosidic linkage of acarbose to produce glucose and a pseudotrisaccharide (Baek et al., 2000). The 
pseudotrisaccharide can be transferred to acceptors forming α-(1→6) linkages, followed by α-(1→3) 
and α-(1→4) glucosidic linkages. Amlyosucrase catalyzes the synthesis of an amylase-like 
polysaccharide composed of only α-(1→4)-glycosidic linkages from sucrose in the presence of glycogen 
(Skov et al., 2001). Cyclodextrin glucanosyl transferases transfer a maltohexaosyl residue from 
cyclomaltohexaose to OH-4 of the acceptor molecule to form linear or branched glucooligosaccharides 
(Vetter, 1992).   
2.2.2. Dextransucrase 
 Dextransucrase (1,6-α-D-glucan-6-α-glucosyltransferase, EC 2.4.5.1) catalyzes the synthesis of 
high molecular weight glucans from sucrose, which contain 50% or more α-1,6 glucosidic bonds as a 
main chain (Monsan et al., 2001). They are produced by Leuconostoc and Streptococcus species, as well 
as by other lactic acid bacteria such as Lactococci and Lactobacilli (Sidebotham, 1974; Monchois et al., 
1999; Monsan et al., 2001). Dextransucrase utilizes sucrose as a high energy donor of glucose instead of 
using a nucleotide diphospho sugar to drive the reaction. Sucrose induces a change in protein 
conformation that activates the catalytic site (Mooser, 1992). The energy in the gluco-fructo glycosidic 
linkage is the same as the energy of a sugar-phosphate linkage in the nucleotide diphospho sugars about 
5 kcal/mole (Robyt, 1998). The properties of dextransucrase, produced from L. mesenteroides are 
affected by the strain. L. mesenteroides B-512 produces an extracellular dextransucrase that synthesizes 
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soluble linear α-1,6-linked dextran with about 5% randomly distributed α-1,3-branched linkages 
containing up to 50 to 100 residues (Robyt and Walseth, 1979). L. mesenteroides B-1299 expresses both 
extracellular and intracellular dextransucrases, synthesizing two types of dextrans-fraction L containing 
27% of α-1,2- and 1% of α-1,3-branches and fraction S containing 35% of α-1,2 branches. L. 
mesenteroides B-742 generates two dextransucrases that produce a fraction S with 50% α-1,3 branched 
linkages, and no α-1,4-branch linkages, and a fraction L with 14% α-1,4- and about 1% α-1,3-branched 
linkages (Kim and Robyt, 1995b). Furthermore, they catalyze the transfer of glucose from sucrose onto 
an acceptor molecule, synthesizing an oligosaccharide in the presence of an acceptor such as maltose or 
isomaltose (Koepsell et al., 1953). Figure 2.1 illustrates dextransucrase catalyzed reactions for dextran 
and oligosaccharides.  
Dextransucrase appears to have a molecular mass of 158-195 kDa, a pH optimum of 5.0-5.5, 
and an optimum temperature of 28-33°C (Naessens et al., 2005; Kim and Robyt 1994b). Low 
concentrations of calcium are necessary for optimal enzyme production (Robyt and Walseth, 1979). The 
addition of Tween 80 stabilizes enzyme activity (1994b). Dextransucrase inhibition by 6,6’-
dithiodisucrose showed a mixed type inhibition pattern (Eklund and Robyt, 1988) while 6-deoxysucrose, 
6-thiosucrose, and α-methyl-D-glucoside showed competitive inhibition (Binder and Robyt, 1985), and 
3-deoxysucrose, 4-deoxysucrose, and 4-chloro-4-deoxy-galactosucrose were noncompetitive inhibitors 
(Tanriseven and Robyt, 1989). Kim et al. (1998) reported that an acarbose effectively inhibited dextran 
synthesis by dextransucrase by a noncompetitive mechanism. The inhibition was caused by a 
disproportionation reaction of dextransucrase with isomaltotriose and a decreased efficiency of the 
maltose acceptor reaction.  
2.2.2.1. Dextran Synthesis 






Figure 2.1. Reaction catalyzed by dextansucrase. I, Glucan synthesis by successive transfer of 
glucosyl units; II, sucrose hydrolysis by transfer of the glucosyl unit onto water; III, oligosaccharide 
synthesis by transfer of the glucosyl unit onto an acceptor molecule; and IV, isotopic exchange by 
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main α-1,6 linkages and sometimes branched with α-1,2, α-1,3, or α-1,4 linkages. It has been widely 
used as a blood volume expander, drug carrier, and chromatographic media due to its non-ionic character 
and good stability (Koepsell et al., 1952; Shamala and Prasad, 1995). It shows structural variation in the 
position of the branch linkages, the degree of branching, the length of branch chains, and molecular 
weight distribution and properties like the degree of solubility in water, depending on the microbial 
strains that produce it, and according to growth rate and reaction conditions (Kim and Robyt, 1995; Kim 
et al., 2001; Padmanabhan and Kim, 2002). 
2.2. 2.1.1. Mechanism for Dextran Synthesis 
 Dextran is synthesized by autopolymerisation utilizing a single chain mechanism by a unique 
type of enzyme. Dextran produced at a low rate of the reaction, is high molecular weight (Bovey, 1959; 
Tsuchiya et al., 1953). Tsuchiya et al. (1953) proposed a mechanism where glucan synthesis may be 
separated into three different steps-initiation, elongation, and termination.  
(1) Initiation of the Reaction 
 Some researchers have been reported that the addition of exogeneous glucan as a primer helps 
the polymerization start glucan synthesis (Kobayashi et al., 1986; Germaine et al., 1974 and 1977). In 
another view, Robyt and Corrigan (1977) negated the necessity of a primer for the initiation of glucan 
synthesis, presenting that glucansucrases are active enzymes in the absence of any exogenous primer. A 
dextran itself remained a strong activator of glucan synthesis as it presents blocked hydroxyl groups 
linked to C6 of the glucosyl residue at its non-reducing end. Also, Robyt et al. (1995) and Mooser (1992) 
proposed that the reaction may be initiated by conformational change by binding of glucan to enzyme in 
the catalytic site.  
(2) Elongation step 
 The mechanism of autopolymerization and direction of chain growth are not yet fully 
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understood (Monchois et al., 1999). 
a. Elongation occurs at the non-reducing end of the glucan chain 
 A carboxyl group, in the presence of an aspartic or glutamic acid, may make a nucleophilic 
attack on C1 of the glucosyl moiety of sucrose, driving the formation of a covalent glucosyl-enzyme 
complex, whereas other acidic groups may facilitate the release of fructose by donating a proton to the 
oxygen atom in the glucosidic link (Sinnot, 1990). A glucosyl residue can be activated by trapping the 
hydrogen from the hydroxyl group linked to C6. Therefore, only one covalent glucosyl-enzyme complex 
is required if glucan biosynthesis follows this mechanism. However, Su and Robyt (1994) disagreed 
with this mechanism because it requires the presence of a primer initiating the glucan biosynthesis and 
seems not to need sucrose in the chain initiation. 
b. Elongation occurs at the reducing end of the glucan chain 
 Robyt et al. (1974) have proposed a mechanism where elongation occurs at the reducing end of 
the glucan chain. Dextransucrase may form an enzymatically active covalent complex with glucose and 
dextran and then glucose is inserted between the enzyme and dextran by a nucleophilic attack of the C6-
OH of glucose onto C1 of the dextran forming an α-1→6 glucosidic bond. The released nucleophile 
attacks another sucrose molecule forming a new enzyme glucosyl intermediate. The C-6 OH group of 
this new glucosyl intermediate attacks C-1 of dextran, which is actually transferred to the glucosyl 
residue (Robyt and Eklund, 1983). The glucosyl (dextranosyl) units are alternatively transferred between 
the two nucleophiles as the dextran chain is elongated at the reducing end. Dextran is built up by 
extrusion from the enzyme when glucose units are transferred from sucrose to the active site and 
inserted between the enzyme and the reducing end of the dextran polymer. An additional requirement for 
this reaction is the transfer of a hydrogen ion to the displaced fructosyl moiety of sucrose. Two 
imidazolium groups of histidine were required to synthesize dextan. These two imidazolium groups gave 
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their hydrogen ions to fructose units left behind and resulting imidazole group becomes reprotonated by 
abstracting a proton from attacking C-6 OH group of the glucosyl-enzyme intermediate, facilitating the 
nucleophilic attack and the formation of α-1→6 linkages. This mechanism does not require exogenous 
primer at the beginning of the reaction for a glucan elongation. The mechanism of action of the enzyme 
from L. mesenteroides NRRL B-512F supports this mechanism, showing the presence of two sucrose 
binding sites (Su and Robyt, 1994).    
2.2.2.2. Oligosaccharide Synthesis  
 The acceptor reaction has many possible technical applications for synthesizing oligosaccharide 
derivatives. Koepsell et al. (1953) found that the dextransucrase changed its pathway for dextran 
synthesis to oligosaccharide synthesis in the presence of a sucrose medium containing maltose, 
isomaltose, or O-α-methylglucoside. It has been reported that various mono-, di-, tri-, and oligo- 
saccharides acted as acceptors for dextransucrase (Robyt, 1995; Robyt and Eklund, 1983; Fu and Roby, 
1990). According to Robyt (1983), maltose and isomaltose are classified as strong acceptors, leucrose 
and sucrose itself do not seem to be able to act as acceptors. Yoon and Robyt (2002) synthesized new 
types of 4-maltohexaosyl acarbose and 4-maltododecanosyl acarbose.  
Demuth et al. (2002) showed that the synthetic potential for dextransucrase is not restricted to 
normal saccharides. They tried to use rather unconventional acceptor compounds-alditols, aldosuloses, 
sugar acids, alkyl saccharides, glycols, fructose dianhydride- as an acceptor molecule and sucrose as a 
donor molecule for transglycosylation by dextransucrase. 
In the acceptor reaction of dextransucrase, the glucosyl group from sucrose is successively 
transferred to the non reducing end of an acceptor molecule making an oligosaccharide that can be 
alternatively product and substrate. However, other acceptors like fructose produce only leucrose (a 
disaccharide) which end glucan synthesis (Stolada et al., 1956). 
59 
 
2.2.2.2.1. Mechanism for Acceptor Reaction 
 According to their ability to compete with glucan synthesis, or their effect on the reaction 
velocity acceptor reactions may be separated into two classes: (1) strong acceptors like maltose or 
isomaltose which are strong inhibitors of glucan synthesis and activators of the reaction velocity and (2) 
weak acceptors like fructose or meliobiose which are weak inhibitors and activators (Robyt and Eklund, 
1983).  
       Robyt and Walseth (1978) proposed that the acceptor reaction requires a single covalent 
glucosyl-enzyme complex and it is incorporated at the reducing end of the glucan or the oligosaccharide, 
producing elongation of the oligosaccharide at the reducing end. Oligosaccharides may be synthesized 
by a nucleophillic attack of the hydroxyl group located at the non-reducing end of the acceptor to the C1 
of one of the two glucosyl residues involved in the two covalent glucosyl-enzyme complexes.  
       Emeline et al. (2005) reported that the acceptor binding site is unique and consists of the two 
active catalytic domains, CD1 and CD2. The CD1 is proposed to be involved in the formation of mainly 
α-1,6 glucooligosaccharides and the CD2 in the synthesis of very few α-1,2 glucooligosaccharides. The 
study using dsrE gene from L. mesenterides NRRL B-1299 found that CD1 possesses a higher catalytic 
efficiency than CD2 in the complete construct. Active domains of both CD1 and CD2 can act 
independently, but alone each shows very low activity. 
2.2.2.3. Substrate Specificity of Dextransucrase 
 Dextran synthesis absolutely requires sucrose, not glucose, mixtures of glucose and fructose or 
any other sugar (Robyt, 1985). The dextransucrase utilizes the relatively high energy (16.7-20.9 kJ mol-1) 
of the acetal-ketal linkage joining the glucose and fructose moieties of sucrose in order to synthesize the 
α-1,6-linkages of the main chain. For this reaction, there are no requirements of ATP or cofactors 
(Leathers, 2002). Even though sucrose is the only naturally occurring substrate, α-D-glucopyranosyl 
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fluoride and p-nitrophenyl-α-D-glucopyranoside can be substrate but have rates much lower than 
sucrose (Robyt, 1985).  
2.2.2.4. Dextransucrase from Leuconostoc mesenteroides B512 FMCM  
 L. mesenteroides NRRL B512 (ATCC 10803) produces a single dextransucrase and synthesizes 
a wide variety of oligosaccharides by glucosyl transfer reactions to acceptors (Robyt and Walseth, 1978; 
Robyt and Ekland, 1983). L. mesenteroides NRRL B-512 F is the most extensively studied and 
commercially important strain (Robyt and Walseth, 1979; Santos et al., 2000). L. mesenteroides requires 
sucrose in the medium for the production of dextransucrase with the exception of constitutive enzyme 
mutants-B-512 FMC, B-742, B-1142, B-1299, and B1355 (Cote et al., 1999; Kim and Robyt, 1995a; 
Kim and Robyt, 1995b; Kitaoka and Robyt, 1998; Monsan et al., 2001; Robyt and Walseth, 1979). The 
growth of L. mesenteroides NRRL B512 F is considered to be positively affected by oxygen even though 
it is a micro-aerophilic strain (Barker and Ajongwhen, 1991; Landon and Webb, 1990; Plihon et al., 
1995; Lebrun et al., 1994).  
 The dextransucrase from L. mesenteroides B512 F synthesizes a dextran that has 95% α-(1→6) 
and 5% α-(1→3) branch linkages (Lindberg and Svensson, 1968). B-512F is the parent of B512 FM, a 
hyper producer of dextransucrase, a mutant produced by nitrosoguanidine (Miller and Robyt, 1984). 
However, L. mesenteroides B512 F dextransucrase is only produced on induction by sucrose and with 
low yields. Consequently, the crude enzyme contains a great deal of dextran (Lindberg and Svensson, 
1968; Robyt and Walseth, 1979). To overcome these problems, Kim and Robyt (1994) developed L. 
mesenteroides B512 FMC, a constitutive mutant produced by ethyl methane sulfonate mutagenesis. Also, 
B512 FMC was mutated to B512 FMCM by irradiation with photons (Kim and Kim, 1999). All strains 
derived from L. mesenteroides NRRL B512 F produced the same type of dextran, whereas their 
activities were different (Kim and Robyt, 1994; Kim and Kim, 1999). B512 FMCM produced 13-times 
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more enzyme than the parent mutant strain, B512 FMC, and over a 100-fold more than the original B-
512F, commercial strain (Kim and Kim, 1999) on sucrose media.  
In the acceptor reaction of dextransucrase from L. mesenteroides B-512F, the acceptors are 
releasing the glucopyranosyl and dextranyl covalent enzyme-intermediates by a nucleophilic 
displacement reaction, which terminates the polymerization of dextran (Robyt and Walseth, 1978). Su 
and Robyt confirmed this mechanism by showing that the active site of B-512FM dextransucrase had a 
single acceptor binding site where the acceptors were bound and could make a nucleophilic attack on the 
glucopyranosyl or dextranyl group to release them from the active site and to form the acceptor products.  
This work reports on optimization of some of the variables that play important roles for the 
production of cellobio-oligosaccharides; they are temperature, pH, enzymatic concentration, and the 
concentrations of sucrose and cellobiose. The cellobio-oligosaccharides were purified and their 
structures were determined.  
2.3. MATERIALS A	D METHODS 
2.3.1. Growth and Culture Conditions 
Leuconostoc mesenteroides B-512 FMCM, a constitutive mutant for dextransucrase production, 
was kindly donated by Dr. Doman Kim (Chonnam National University; Kim and Kim, 1999). The 
culture was maintained at 30˚C in LM medium [0.5% (w/v) yeast extract, 0.5% (w/v) peptone, 2% (w/v) 
K2HPO4, 0.02% (w/v) MgSO4·7H2O, 0.001% (w/v) NaCl, 0.001% (w/v) FeSO4·7H2O, 0.001% (w/v) 
MnSO4·H2O, 0.013% (w/v) CaCl2·2H2O] containing 2% glucose or 2% sucrose. It was maintained on 
glucose-LM medium containing 2% glucose and 1.5% agar at 4˚C, and was transferred biweekly. For 
growth measurement, samples of 5 ml were taken at desired times for 48 hours. Bacterial growth was 




2.3.2. Enzyme Production 
L. mesenteroides B-512 FMCM was sub-cultured by three successive transfers including 1 ml 
sucrose-LM and glucose-LM medium, 40 ml, and 1 L glucose-LM media to build sufficient volume for 
inoculation of the final fermentation. The inoculums were 2-5% (v/v) with cultures grown for 16 hours 
at 30˚C with shaking at 150 rpm. For dextransucrase production, a 400 ml culture was inoculated to 14 L 
of LM medium containing 2% glucose and incubated for 48 hours at 30˚C. The pH and agitation were 
not controlled during fermentation. After harvesting, cells were removed by centrifugation at 6,000 rpm 
x g for 30 minutes. The cell free culture was concentrated 10-fold using membrane filtration (100K cut 
off) and washed with 2 volumes of 20 mM sodium citrate buffer, pH 5.2.  Tween 80 and NaN3 were 
added at concentrations of 1 mg/ml and 0.2 mg/ml to enzyme solution.  
2.3.3. Dextransucrase Assay 
Dextransucrase activity was determined by incubating the enzyme with 100 mM sucrose in 20 
mM sodium citrate buffer, pH 5.2 for 1 hour at 30˚C and then boiling for 5 minutes to terminate the 
enzyme reaction. One unit of dextransucrase activity was defined as the amount of enzyme releasing 1 
µM fructose per minutes from 100 mM sucrose. The fructose was determined by HPLC. Also, relative 
fructose concentration was measured by TLC. The methods for HPLC and TLC are described below. 
2.3.4. Enzyme Characterization 
Protein assay was determined using Bio-radTM protein assay kits following the method of 
Bradford (Bradford, 1976). Enzyme size was determined by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). In order to determine optimal pH and temperature, reaction digests 
consisted of 100 mM sucrose, 100 mM cellobiose, and 27 U dextransucrase were incubated for 24 hours 
under various conditions-pHs ranging from 3.2 to 6.0 and temperatures from 20-50˚C. 
Transglycosylation products were measured by HPLC. 
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2.3.5. Box-Behnken Experimental Design 
A three-factor and three-level Box-Behnken design was applied for the optimization procedure 
using Design Expert 6 software (Stat-Ease, Inc.). Several factors-the amounts of sucrose, cellobiose, and 
dextransucrase-used to prepare each of the 17 formulations are given in Tables 2.1. and 2.2. These high, 
medium, and low levels were selected from the preliminary experimentation. Optimization was 
performed using a desirability function to obtain the levels of X1, X2, and X3.  
The behavior of the system has been explained by the following quadratic model equation:  
Y = β0 + β1X1 + β2X2 + β3X3 + β11X1
2 + β22X2
2 + β33X3
2 + β12X1X2 + β13X1X3 + β23X2X3  
where Y is predicted response, β0 intercept, β1, β2, and β3 linear coefficient, β11, β22, and β33 squared 
coefficients and β12, β13, and β23 interaction coefficients. A total of 17 experiments were necessary to 
study the 10 coefficients of model. 
2.3.6. Thin Layer Chromatography 
The fructose for dextransucrase activity and oligosaccharides were analyzed by using thin layer 
chromatography (TLC). The TLC samples were loaded onto a Whatman K5 silica gel plate. For 
determination of fructose concentration, the plate was irrigated twice with 85% (v/v) acetonitrile. For 
oligosaccharides, it was irrigated three times with 2:5:1.5 volume parts of nitromethane-1-propanol-
water. The carbohydrates on the TLC plate were visualized by dipping the plate into a methanol solution 
containing 0.3% (w/v) N-(1-naphthyl) ethylenediamine and 5% (v/v) sulfuric acid, followed by heating 
at 110˚C for 15 minutes. The relative percent of carbohydrates was determined using Scion image 
analyzer software.  
2.3.7. High Performance Liquid Chromatography 
Concentrations of fructose and crude oligosaccharides were measured by high performance 
liquid chromatography (HPLC) using an Aminex HPX 87K column (300 mm x 7.8 mm) and HPLC  
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Table 2.1. Variables in Box-Behnken design 
Independent variables Levels 
Low Middle High 
X1: sucrose (mM) 100 250 400 
X2: cellobiose (mM) 50 150 250 
X3: dextransucrase (U) 27 40 54 
 
Table 2.2. Formulations for Box-Behnken design 
 Run X1 X2 X3 
1 100 50 40 
2 100 150 27 
3 100 150 54 
4 100 250 40 
5 250 50 27 
6 250 50 54 
7 250 150 40 
8 250 150 40 
9 250 150 40 
10 250 150 40 
11 250 150 40 
12 250 250 27 
13 250 250 54 
14 400 50 40 
15 400 150 27 
16 400 150 54 





analyzer coupled to a refractive index detector. The column was maintained at 85˚C and 0.01 M K2SO4 
was used as a mobile phase at a flow rate, 0.6 ml/min. 
2.3.8. High Performance Anion Exchange Chromatography 
The enzyme reaction products were analyzed by high performance anion exchange 
chromatography (HPAEC) using a Dionex Carbo-Pac PA 100 column (250 x 4 mm) by gradient elution 
using 1 M NaOH, water, and 480 mM sodium acetate at a constant flow rate of 0.5 mL/min. 
Oligosaccharide detection was carried out with an electrochemical detector (ED 40).  
2.3.9. Production of Cellobio-oligosaccharides 
Transglycosylation reactions were performed in 500 ml of 20 mM citrate buffer (pH 5.2) 
including 300 mM of sucrose, 250 mM of cellobioe, 54 U dextransucrase at 30˚C with shaking at 150 
rpm. The reaction was performed until the sucrose was depleted and then terminated by heating for 20 
minutes at 95˚C. A reaction product was centrifuged at 6,500 rpm for 45 minutes for the removal of 
insoluble polysaccharide. The soluble polysaccharide was precipitated with an equal volume of ethanol 
which was slowly added to the supernatant and the resulting solution stored in a refrigerator for 2 hours. 
The precipitate was eliminated by centrifugation at 6,500 rpm for 45 minutes. The supernatant was 
analyzed by HPLC, TLC, and HPAEC as described above. The supernatant was concentrated 10-fold 
using a rotary evaporator and then freeze dried.  
2.3.10. Purification of Cellobio-oligosaccharides 
The crude oligosaccharide solution was loaded onto Bio-Gel P2 (fine) column (1.5 cm x 115 
cm), and eluted with water. It was collected in 0.5-1.0 ml fractions. Their purities were analyzed using 
either TLC or HPAEC mentioned above. Those fractions with the same DP were pooled and freeze dried. 
2.3.11. Liquid Chromatography-Mass Spectrometry 
Mass spectrometry data of the purified oligosaccharides were obtained from electrospray (MS-
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ES) measurements. The solvent was ultrapure water at 7 µl/min-1 and detection was performed in the 
positive mode.  
2.3.12. 	uclear Magnetic Resonance 
About 50 mg from the purified oligosaccharides were exchanged three to four times with 600 µl 
of pure D2O and lyophilized twice, and then dissolved in 600 µl of pure D2O, and placed into NMR 
tubes. NMR spectra were produced using a spectrometer, operating at 500 MHz for 1H and 125 MHz for 
13C at 25˚C. It was examined for the linkages between cellobiose and glucose from homonuclear 
correlation spectroscopy(COSY), total correlation spectroscopy (TOCSY), rotating frame overhause 
effect spectroscopy (ROESY), heteronuclear single quantum coherence (HSQC), and heteronuclear 
multiple quantum coherence spectroscopy (HMQC) spectra. 
2.3.RESULTS A	D DISCUSSIO	 
2.4.1. Production of Dextransucrase 
 L. mesenteroides B-512 FMCM, a mutant strain of L. mesenteroides B-512, produced 
dextransucrase without any dextran contamination on glucose-LM medium. Its growth, production of 
dextransucrase, and pH changes of media were examined (Figure 2.2). The maximum cell concentration 
(OD 660 nm 1.18) was obtained at the 27th hour. According to Cortezi et al. (2005), extracellular 
dextransucrase production was closely related to bacterial growth when 3-4% sucrose was used as a 
carbon source. We found that the production of dextransucrase was commenced 12 hours after growth 
started. The highest enzyme activity, 0.332 U/mg protein, was found in the late stationary phase between 
30 and 44 hours. Production and activity of enzyme seemed not to be affected as the pH of medium 
dropped below 4.8, a beyond pH range some researchers (Alsop, 1983; Chen and Kaoli, 1976) reported. 
L. mesenteroides grown on sucrose medium as a carbon source has been reported to produce maximum 
dextransucrase at pH 6-7. Tsuchiya et al. (1952) found that dextransucrase production is optimal at pH  
 
 
Figure 2.2. The growth of L. mesenteroides
dextransucrase. Cells were incubated for the production of dextransucrase in a LM medium containing 
2% glucose at 30˚C. All samples were collecte
growth and pH changes, stored at 0˚C for dextransucrase activity assay. For dextransucrase activity, all 
samples were incubated with 100 mM sucrose at 30˚C for 1 h and fructose were measured using TLC a
the same time. Dextransucrase activity was indicated as their relative activity which is the % of fructose 











 B-512 FMCM, pH changes, and the production of 





values between 7 and 8, but the enzyme denatured irreversibly when maintained at that pH range for an 
extended period of time. However, Padmanabhan and Kim (1992) produced dextransucrase at 
approximately pH 5.  
2.4.2. Enzyme Characterization 
The concentrated dextransucrase used for transglycosylation reaction had a specific activity of 
22.15 U/mg total protein. Its size was 180 kDa by SDS-PAGE after Rf values were calculated using 
distances of bands in a standard marker and dextransucrase (Figure 2.3). The filtration step using a 100 
kDa membrane filter effectively removed sucrose catalyzed enzymes; the 65 kDa isomerase and the 55 
kDa sucrose phosphorylase. The dextransucrase occurs in multiple molecular forms due to enzyme 
aggregation (Robyt and Walseth, 1979).  
The optimum pH for cellobio-oligosaccharide production was 5.2 (Figure 2.4). The optimum 
pH for oligosaccharide production was the same as that for dextransucrase activity (Kim and Robyt, 
1994a). The production of cellobio-oligosaccharides was more sensitive to the changes in pH than was 
dextransucrase activity. Dextransucrase produced 39% cellobio-oligosaccharide at pH 6.2 comparing to 
100% cellobio-oligosaccharide production at pH 5.2.  
There was a sharp decrease in the production of cellobio-oligosaccharides by dextransucarse 
above 30˚C (Figure 2.5). It only transglycosylated 46 % of the glucosyl units from sucrose to cellobiose 
of the maximum at 40˚C. Dextransucrase for oligosaccharide production has the same pattern as the 
effect of temperature of dextransucrase activity on temperature changes (Kim and Robyt, 1994a). 
2.4.3. Box-Behnken Design 
Table 2.3 depicts the actual and predicted values of cellobio-oligosaccharides on the basis of the 
experimental design (Kim and Day, 2007). The predicted values and the observed values agreed 
reasonably well. Concerning the p-value of the coefficients, X1, X2, X3, and X1
2 were found to have  
 
Figure 2.3.  SDS-PAGE of dextransucrase of 
standard marker (175 kDa of MBP-
coli, 62 kDa of glutamic dehydrogenase from bovine liver, 47.5 kDa of aldolase from rabbit muscle, 
32.5 kDa trisephosphate isomerase from 
lysosyme from chicken egg white, and 6.5 kDa of aprotinin from bovine lung; New England BioLabs 











L. mesenteroides B-512 FMCM. 
β-galactosidase from E. coli, 83 kDa of MBP-
E. coli, 25 kDa of CBD-BmFKBP13 from 
 
Standard means a 
paramyosin from E. 





Figure 2.4. Production of cellobio-oligosaccharides synthesized by L. mesenteroides B-512 FMCM 
dextransucrase at various pH values.  
1Relative activity for cellobio-oligosaccharide production was calculated as the percentage concentration 
of cellobio-oligosaccharides at the selective pH, divided by the highest concentration of cellobio-
oligosaccharides over all pH ranges. 



















































Figure 2.5. Oligosaccharides produced as a function of temperature changes. 
1Relative activity for cellobio-oligosaccharide production was calculated as the percentage concentration 
of cellobio-oligosaccharides at the selective temperature, divided by the highest concentration of 
cellobio-oligosaccharides over all temperature ranges. 















































Table 2.3.  Observed and predicted values and variance parameters of cellobio-oligosaccharide yield 
(%) recorded in experimental set up of response surface methodology 
 
Run # Observed Y Predicted Y Residuals 
1 33.60 30.83 2.77 
2 35.72 36.37 -0.65 
3 63.25 65.39 -2.15 
4 64.12 64.09 0.02 
5 35.29 37.51 -2.23 
6 73.67 74.19 -0.52 
7 66.78 71.25 -4.47 
8 66.88 71.25 -4.36 
9 74.76 71.25 3.51 
10 76.06 71.25 4.81 
11 71.77 71.25 0.52 
12 63.90 63.27 0.62 
13 100.00 97.88 2.12 
14 54.34 54.37 -0.02 
15 47.29 45.04 2.25 
16 87.84 87.29 0.55 











significant effects on the performance of the model for the prediction of the cellobio-oligosaccharide 
production (Tables 2.4 and 2.5; Kim and Day, 2007).  
The final estimative response model equation was as follows: 
Y = 71.91 + 7.64X1 + 12.36X2 + 17.82X3 -12.98X1
2 -3.29X2
2 -0.41X3
2 - 4.25X1X2 + 3.31X1X3 -0.52 
X2X3  
where Y is the response factor (cellobio-oligosaccharide production, %) and X1, X2 and X3 
represent real values of the independent factors–sucrose (mM), cellobiose (mM) and dextransucrase (U). 
Table 2.4 shows the model coefficients and probability values (Kim and Day, 2007). The ANOVA of this 
model (Table 2.5; Kim and Day, 2007) demonstrated that the model is highly significant, as is evident 
from the F (Fmodel = 35.99) and a very low probability value (<0.0001). The P value lower than 0.1 
indicates that a model is considered to be statistical significant (Kim et al., 2003). Also, F-value of 0.64 
for the lack of fit implies that it is not significant relative to the pure error according to our results of 
analysis of factors. Non-significant lack of fit is a good indication that the model fits the actual 
relationships of the reaction parameters within the selected ranges. 
The relationship between the independent and dependent variables was elucidated using contour 
and response surface plots (Figure 2.6; Kim and Day, 2007).  Each plot represents the effect of two 
variables at their studied range with the other one maintained at fixed level. The shapes of contour plots 
display the nature and extent of the interactions (Fu et al., 2006).  As shown in Figure 2.6a, an increase 
in sucrose concentration up to 300 mM results in increased cellobio-oligosaccharide production with 
increases in cellobiose concentration at 40.5 U dextransucrase. An increase in the concentration of 
cellobiose causes a linear increase in cellobio-oligosaccharide produced. However, sucrose 
concentrations greater than 300 mM interfere with cellobio-oligosaccharide production despite increases 
in the concentrations of cellobiose. The reaction solutions became increasingly viscous with increases in  
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Table 2.4. Regression coefficients and significance of regression model 
 
Factor Coefficient estimate DF Standard error 95% CI low 95% CI high 
Intercept 71.91 1 1.78 67.70 76.12 
X1 7.64 1 1.41 4.32 10.97 
X2 12.36 1 1.41 9.04 15.69 
X3 17.82 1 1.41 14.50 21.14 
X1
2 -12.98 1 1.94 -17.56 -8.40 
X2
2 -3.29 1 1.94 -7.87 1.29 
X3
2 -0.41 1 1.94 -5.00 4.18 
X1X2 -4.25 1 1.99 -8.95 0.45 
X1X3 3.31 1 1.99 -1.39 8.01 
X2X3 -0.52 1 1.99 -5.22 4.18 











Table 2.5. ANOVA for response surface 
Source Sum of squares DF Mean square F-value Probability >F
a,b
 
Model 5119.29 9 568.81 35.99 <0.0001 
X1 466.80 1 466.80 29.53 0.0010 
X2 1221.61 1 1221.61 77.29 <0.0001 
X3 2540.51 1 2540.51 160.73 <0.0001 
X1
2 709.29 1 709.29 44.87 0.0003 
X2
2 45.53 1 45.53 2.88 0.1335 
X3
2 0.69 1 0.69 0.04 0.8400 
X1X2 72.19 1 72.19 4.57 0.0699 
X1X3 43.83 1 43.83 2.77 0.1398 
X2X3 1.08 1 1.08 0.07 0.8014 
Residual 110.64 7 15.81   
Lack of fit 35.87 3 11.96 0.64 0.6282 
Pure error 74.77 4 18.69   
Correlation total 5229.93 16    
aProbability > F, level of significance. 
bValues of “probability > F” less than 0.05 indicate model terms are significant. Values greater than 0.1 











































































































































































































































































































































































































































































































































































































sucrose concentration due to the concomitant formation of dextran. This finding is similar to that 
reported for the action of sucrose on the dextransucrase production by L. mesenteroides B-512 F (Goyal 
and Katiyar, 1997). 
The effects of varying dextransucrase and sucrose concentrations on the cellobio-
oligosaccharide production with 150 mM cellobiose are shown in Figure 2.6b. Highest production of 
cellobio-oligosaccharides was achieved at the middle range of sucrose concentration across the entire 
range of dextransucrase concentration. A linear increase in dextransucrase does not lead to a continual 
increase of cellobio-oligosaccharide production with increases in sucrose concentration.  Product 
inhibition was observed due to dextran formation above 54 U of dextransucrase (data not shown). 
Dextransucrase catalyzes dextran synthesis as well as oligosaccharide synthesis. Kim and Robyt (1994b) 
reported that dextran production showed a slightly sigmoidal increase suggesting an allosteric effect for  
the dextran. 
Figure 2.6c illustrates the effects of different dextransucrase concentrations and cellobiose 
concentrations on the cellobio-oligosaccharide production in the presence of 250 mM sucrose. Increases 
in the amount of both dextransucrase and cellobiose resulted in linear increases in the production of 
cellobio-oligosaccharides when sucrose concentration was fixed. The highest concentrations were 
reached using high dextransucrase and cellobiose. However, the addition of cellobiose was limited by 
the solubility of cellobiose. Figure 2.7 suggests that high cellobiose and dextransucrase as well as 
sucrose concentration between 250 and 300 mM achieve the optimal transglycosylation of sucrose to 
cellobiose. The optimum values for the selected factors were calculated from the regression equation. 
The optimal conditions for the cellobio-oligosaccharides were as follows: X1 = 288.96 mM, X2 = 250 
mM, X3 = 54 U. The theoretical cellobio-oligosaccharide yield predicted under these conditions was 






Figure 2.7. Response surface plot representing the effect of varying concentrations of sucrose, 
cellobiose, dextransucrase on their reciprocal interactions with cellobio-oligosaccharide. 
Dextransucrase is held constant at 54 U. The reactions were performed in 20 mM citrate buffer, pH 5.2 


































  A: Sucrose  
  B: Cellobiose  
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2.4.4. Transglycosylation Reaction 
 Dextransucrase from L. mesenteroides B-512FMCM catalyzed an acceptor reaction between 
cellobiose and sucrose. As shown in Figure 2.8, cellobiose acceptor reaction products display a 
cellobiose-oliogsaccharide peak, whereas dextran synthesis reaction in the absence of cellobiose does 
not. However, HPLC chromatograms were not capable of separating each oligosaccharide of the 
cellobio-oligosaccharides. Using HPAEC chromatogram, we obtained one major product (B), several 
minor products (A, C, D, and E), fructose and leucrose (Figure 2.9). The product A and B had the same 
position on TLC (Figure 2.9). 
 The cellobio-oligosaccharide yields were shown in Table 2.6. Transglycosylation reaction 
between cellobiose and sucrose by L. mesenteroides B-512 FMCM dextransucrase produced 10.7 mg/ml 
cellobio-oligosaccharides. The concentrations were 1.5 mg/ml of A, 5.5 mg/ml of B, 1.4 mg/ml of C, 1.4 
mg/ml D, and 0.9 mg/ml of E.  
2.4.5. Purification of Cellobio-oligosaccharides 
 The transglycosylation products were fractionated by Bio-Gel P2 gel permeation 
chromatography (Figure 2.10). Unreacted cellobiose and glucose, and by-products of transglycosylation, 
leucrose and fructose were removed from reaction products, A, B, C, D, and E. Each reaction product 
was purified and separated for structure analysis and experiments on biological activity. 
2.4.6. Mass Spectrometry 
 The numbers of D-glucose units that were reacted with cellobiose for products A, B, C, D, and 
E were determined by using MALDI-TOF MS. The data for molecular masses were detected in the 
positive mode and their masses determined after Na+, mass (22.99 g/mol), was removed. The mass of 
the product A and B indicated 504.07 g/mol (Figure 2.11a), C 666.02 g/mol (Figure 2.11a), D 828.28 
(Figure 2.11b), and E 990.33 (Figure 2.11b). The masses of these reaction products increased over that




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.6. Concentration and apparent yield of cellobio-oligosaccharides. 
 
Compound Concentration (mg/ml) Apparent yield (%) 
A 1.5 14.0 
B 5.5 52.7 
C 1.4 12.9 
D 1.4 13.3 
















































































































































































































































Figure 2.11a. MALDI-TOF MS analysis of transglycosylation products by the dextransucrase 
mesenteroides B-512 FMCM. (A) Products
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Figure 2.11b. MALDI-TOF MS analysis of transglycosylation products by the dextransucrase 
mesenteroides B-512 FMCM. (C) product
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of cellobiose by exactly a single D-glucose residue (M.W. 162 g/mol). Therefore, A and B were 
trisaccharides, C was tetrasaccharide, D was pentasaccharide, and E was a hexasaccharide. 
2.4.7. 	MR Spectrometry 
 The structures of the major transglycosylation products-A and B were determined by 1H and 13C 
nuclear magnetic resonance (NMR) spectrometry in order to determine the synthetic modes of cellobio-
oligosaccharides. The proton signals were assigned from analyses of 1H/1H-COSY and 1H/1H-TOCSY 
spectra. After the assignment of all proton signals, the corresponding 13C resonances were allowed by 
1H/13C-HSQC spectrum, followed by ROESY and HMQC. All assignments of the cellobio-
oligosaccharides are shown in Table. 2.7. 
 The NMR assignments indicated two forms of trisaccharides. We noted a smaller amount of 
trisaccharide as a product A and a larger amount of trisaccharide as a product B. When the integral of 
III-1 proton at 5.06 ppm was determined as 1, the total integrals of two III-1 proton at 5.33 and 4.96 ppm 
were 2.2 (Figure 2.12). Therefore, a trisaccharide having III H-1 at 5.06 ppm was determined as a 
product A and the other as a product B.  
 The new anomeric proton signal at 5.06 ppm (J = 3.5 Hz, doublet signal) was assigned, 
indicating that a glucosyl residue was connected to cellobiose with α-linkage (Agrawal, 1992). In a 
product A, the 13C-chemical shift in cellobiose before and after the addition of α-D-glucopyranose to 
cellobiose for C-6 was changed from 60.932 ppm to 66.354 ppm (Table 2.7 and Figure 2.13). This 
chemical shift change is characteristic of the attachment of a D-glucopyranose unit to the original 
glucoside or aglycone (Agrawal, 1992; Yoon et al., 2004; Kono et al., 1999). Except for this change for 
C-6, the spectra of a product A gave no resonance changes. Therefore, the NMR result indicates that the 
D-glucopyranose unit was attached to the cellobiose ring by an α-(1→6) linkage. The cellobio- 




1H NMR and 13C NMR chemical shiftsa for product A and B produced by the reaction of 
dextransucrase with sucrose and cellobiose (units: ppm). 
 











 92.20 92.33 0.13 5.19 89.70 -2.51 5.41 
  2 71.60 71.83 0.24 3.56 70.33 -1.27 3.65 
  3 
71.71 72.28 0.58 3.94 72.24 0.53 3.94 
  4 
79.11 79.03 -0.07 3.68 79.06 -0.05 3.68 
  5 70.48 70.40 -0.08 3.89 70.40 -0.08 3.89 
  6 
60.28 60.63 0.35 3.80 60.28 0.00 3.90 
 β-Glc 1 96.12 96.54 0.41 4.78 96.31 0.18 4.63 
  2 74.26 73.58 -0.68 3.39 73.74 -0.51 3.27 
  3 
74.66 73.46 -1.20 3.70 73.82 -0.84 3.49 
  4 78.97 79.07 0.10 3.69 79.87 0.90 3.61 
  5 75.16 73.58 -1.59 3.67 73.79 -1.37 3.47 
  6 
60.42 61.232 0.81 3.89 61.13 0.71 3.72 
II β-Glc 1 102.93 103.46 0.53 4.50 102.84 -0.09 4.48 
  2 
73.54 73.30 -0.24 3.30 76.73 3.20 3.30 
  3 
76.86 76.12 -0.74 3.49 76.12 -0.74 3.49 
  4 69.82 70.11 0.28 3.37 69.72 -0.10 3.38 
  5 
76.34 75.32 -1.02 3.62 75.10 -1.24 3.71 
  6 
60.94 66.35 5.42 3.88 61.28 0.34 3.68 
III α-Glc 1  96.89  5.06 98.30/ 98.59  5.33/ 4.96 






  3  73.37  3.77 73.37  3.77 
  4  69.82  3.43 69.82  3.43 






  6  61.31  3.78 61.31  3.78 
aChemical shifts were measured at 125 MHz for 13C NMR and 500 MHz for 1H NMR in D2O at 25˚C 
with acetone as an internal standard. 
bα-D-glucopyranosyl-(1→6)-cellobiose. 
cα-D-glucopyranosyl-(1→2)-cellobiose. 
dEach of the residues of cellobio-oligosaccharide is designed by Roman Numerals, started with I at the 
reducing-end residue. 





H 	MR spectrum of A [α
glucopyranosyl-(1→2)-cellobiose] in D











-D-glucopyranosyl-(1→6)-cellobiose] and B [α








C 	MR spectra of (a) cellobiose and (b) α
α-D-glucopyranosyl-(1→2)-cellobiose.













In a product B, the 1H chemical shifts of the new anomeric carbon (C-1) were 5.33 and 4.96 
ppm with a coupling constant of 3.5 Hz, indicating that they were α-conformation (Table 2.7 and Figure 
2.12; Agrawal, 1992). The corresponding 13C chemical shifts appeared at 98.29 and 98.59 ppm (Table 
2.7 and Figure 2.13). According to Bock et al. (1986), a 13C chemical shift of C-1 in α-D-glucopyranose-
(1→2)-β-D-glucopyranose was 98.6 ppm, indicating an α-(1→2) linkage. Evidence for this linkage was 
supported by a downfield 13C shift for II C-2 of cellobiose from 73.54 to 76.73 (Table 2.7 and Figure 
2.13). These results identified the cellobio-oligosaccharide structure as α-D-glucopyranosyl-(1→2)-β-D-
glucopyranosyl-(1→4)-D-glucopyranose (Figure 2. 14b). 
Our finding was agreed with Morales et al. (2001) who reported that L. mesenteroides B-512 F 
dextransucrase synthesized α-D-(1→2)-glucopyranosyl cellobiose and α-D-(1→6)-glucopyranosyl 
cellobiose in the presence of cellobiose. Besides these two products, they produced α-D-glucopyranosyl- 
 (1→3)-α-D-glucopyranosyl-(1→6)-α-D-glucopyranosyl-(1→6)-cellobiose and α-D-glucopyranosyl-
(1→6)-α-D-glucopyranosyl-(1→6)-cellobiose when cellobiose was used the acceptor molecule by 
alternansucrase from L. mesenteroides B-23192. However, dextransucrase from L. mesenterodies B-512 
F is known primarily to transfer the D-glucose residue from sucrose to the non-reducing end 6-hydroxyl 
group of mono- and higher-saccharides in the presence of an acceptor molecule (Robyt, 1995; Robyt and 
Eklund, 1983). Interestingly, the synthesis of oligosaccharides by L. mesenteroides B-512 F 
dextransucrase apparently depends on the type of acceptor molecule. In the presence of a β-glucosidic 
linkages in the acceptor molecule, the specificity of dextransucrase is changed to transfer the 2-OH 
group at the reducing end glucose rather than transfer 6-OH at the non-reducing end (Yoon and Robyt, 
2002; Robyt, 1995; Robyt and Eklund, 1983). It transfers the D-glucose residue to the non-reducing end 
OH of maltose or isomaltose in the presence of maltose or isomaltose whereas it transfers D-glucose 





Figure 2.14. Proposed chemical structures of (a) α
D-glucopyranosyl-(1→2)-cellobiose










-D-glucopyranosyl-(1→6)-cellobiose and (b) α










presence of maltotriose and maltotetraose (Fu and Robyt, 1990). When the acceptor molecule is lactose 
or raffinose, L. mesenteroides B-512 F dextransucrase transfers D-glucose from sucrose to the OH group 
at C-2 of the D-glucose residue (Robyt, 1995; Robyt and Eklund, 1983).  
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Oligosaccharides have been widely used in food, feed, pharmaceutical, and cosmetic industries 
due to their beneficial effects in humans and animals (Eggleston and Cote, 2003). There is great interest 
in various physiological functions of oligosaccharides such as immune-stimulation, anti-cariogenic, and 
prebiotic effects as well as uses for sweeteners, stabilizers, and bulking agents (Eggleston and Cote, 
2003; Otaka, 2006). Most of the beneficial effects related to health have originated from their role as 
inhibitors of enzymes involved in carbohydrate metabolism.  
Dental caries is acid induced decay of the teeth which is mainly caused by colonization by oral 
streptococci primarily Streptococcus mutans and S. sobrinus (Michalek and Childers, 1990). Oral 
streptococci secrete a mutansucrase which synthesizes from sucrose to glucans with a majority of α-(1-
3)-glucosidic linkages and a highly branched structure (Wenham et al., 1981; Freedman et al., 1978). α-
(1-3)-D-Glucan produced by mutansucrase, called a mutan, is an adherent, and water insoluble 
polysaccharide (Guggenheim and Newbrun, 1969). Mutans mediate interactions and accumulation of the 
bacteria to tooth surfaces, such that they induce the development of dental caries (Lee 2005; Rolla et al., 
1983). Certain oligosaccharides, but not based on cellobiose, have been reported as preventing the 
occurrence of dental caries (Otaka, 2006).  
The α-glucosidase inhibitors have been utilized in the therapeutic treatment of the metabolic 
diseases-diabetes and obesity in conjunction with α-amylase (Asano et al., 2000; Watanabe et al., 1997). 
The α-glucosidase inhibitors can effectively overcome a side effect of α-amylase inhibitors, flatulence 
by intestinal bacteria caused by undigestible polysaccharides, since α-glucosidase inhibitors catalyze the 
final step in dietary carbohydrate (Bischoff, 1995; Lee, 2005; Truscheit et al., 1981). α-Glucosidase 
inhibitors interfere with the conversion of maltose to glucose and suppress postprandial hyperglycemia 
(Watanabe et al., 1997). An acarbose consisting of acarbosine and maltose linked with α-1,4-glucosidic 
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linkage is a well known α-glucosidase inhibitor that has been used to reduce postprandial hyperglycemia 
(Truscheir et al. 1981; Watanabe et al., 1997).  
An opportunistic infectious disease, invasive aspergillosis has emerged as a major cause of 
morbidity and mortality in immunocompromised people (Denning et al., 1998; Lin et al., 2001). 
Aspergillus fumigates, A. flavus, and A. terreus are the species which cause about 95% of the pathogenic 
cases (Richardson and Warnock, 2003). Recently, A. terreus infection has emerged as a growing concern 
because it produces different epidemiological features, a more aggressive clinical behavior, and a much 
higher mortality rate than infection caused by other Aspergillii (Castόn et al., 2007; Steinbach et al., 
2004). Mortality has been reported to reach 100% in patients infected by A. terreus. A. terreus is 
completely resistant to a widely used antifungal drug, amphotericin B (AmB) (Lass-Flörl et al., 1998; 
Johnson et al., 2000). 
 1,3-β-D-Glucan synthase (GS) catalyzes the synthesis of 1,3-β-D-glucan, a vital structural 
polymer of the fungal cell wall that is also a potential antifungal target for therapy of serious fungal 
infections (Huang et al., 1990; Tkacz, 1992). The 1,3-β-D-glucan of fungal cell is unique, not being 
found in other eukaryotes. Consequently, GS inhibitors can be excellent antifungal agents with showing 
a high target specificity, reducing side effects to the host. Echinocandins, pneumocandins, and 
papulacandins are examples of GS inhibitors, but they each have some drawbacks such as 
ineffectiveness against some fungal species and insolubility (Kurtz et al., 1994; Latgé, 2007; Hector, 
1993). 
3.2. LITERATURE REVIEW 
3.2.1. Beneficial Health Effects of Oligosaccharides 




Table 3.1. Summary of various beneficial functions of oligosaccharides  
Functions Oligosaccharides Beneficial health effects 
Indigestibility 
Most oligosaccharides except for 










Improved intestinal microbiota 
Improved tolerance to lactose, 
Protection from gastroenteritis, 
Prevention of bowl cancer  
Prevention of coronary heart disease, 














Enhances immune system with 
increased IgA and lymphocyte 
aOku, 1996; bZiemer and Gibson, 1998; cFuller and Gibson, 1997; dProbert et al., 2004; eGopal et al., 
2001; fFlickinger et al., 2000; gDjouzi et al., 1995; hKabel et al., 2002; iOoshima et al., 1983; jHidaka, 














3.2.1.1. Indigestibility  
Most oligosaccharides provide less metabolic energy than sucrose because they are either not or 
poorly hydrolyzed by digestive enzymes (Oku, 1996). Only selected intestinal bacteria can metabolize 
nondigestible oligosaccharides (Oku, 1996; Nakamura, 2004). The ability of selected bacteria to use 
these oligosaccharides impacts other beneficial effects of oligosaccharides. Neosugar, a mixture of 
fructooligosaccharides such as kestose, nystose, and fructofuranosyl nystose, is not digested in the small 
intestine but rather reaches the large intestine where it is completely fermented by the intestinal bacteria 
(Tokunaga et al., 1989; Oku, 1996). When Neosugar was injected intravenously into a rat, it was not 
hydrolyzed by any enzymes in organs and was not decomposed when it reached the urine (Tokunaga et 
al., 1989). Orally administered Neosugar postponed the release of CO2 about 3 hours compared with 
orally administered sugar (Tokunaga et al., 1989). When Neosugar was incubated anaerobically with the 
cecal content of rats, short-chain fatty acids (SCFAs) as well as CO2 were released spontaneously 
(Tokunaga et al., 1989). Similar observations were made on the metabolism of oligosaccharides such as 
raffinose, stachyose, lactulose, galactosyl-sucrose, 4’ galactooligosaccharide, 6’galactooligosaccharides, 
xylooligosacchaides, lacitol, isomaltitol, and maltitol (Oku, 1994). When the combustion energy of 
SCFA released by intestinal bacteria was used as the energy value of oligosaccharides, the average value 
of nondigestible oligosaccharides was 2.71 kcal/g (Livesey and Elia, 1988; Miller and Wolin, 1979; 
Smith and Bryant, 1979; Tokunaga et al., 1989). But, the value should be recalculated as 1.87 kcal/g, as 
there is only a 69% of apparent utilization efficiency of SCFAs. This value is less than 50% of energy 
value of sucrose (4 kcal/g) (Tokunaga et al., 1989).  
3.2.1.2. Prebiotic Effect 
Prebiotics are defined as nondigestible food ingredients that beneficially affect the host by 
selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon, so 
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improving host health (Gibson and Roberfroid, 1995). Metabolism of prebiotics follows the same 
pattern as low calorie food. Prebiotics stimulate beneficial microflora such as the Bifidobacteria and 
Lactobacillii, and suppress harmful bacteria such as Clostridium sp. and Eubacterium sp. (Gibson and 
Wang, 1994; Gibson and Roberfroid, 1995). Beneficial bacteria produce a large amount of SCFAs and 
cause pH decreases in the lumen of the large intestine (Gibson and Wang, 1994; Gibson and Roberfroid, 
1995). They can survive in acidic condition, whereas less desirable bacteria are generally sensitive to the 
acidic conditions (Gibson and Wang, 1994; Gibson and Roberfroid, 1995). As a result of selective 
fermentation, the composition of the intestinal microbiota is altered towards a healthier balance (Gibson 
and Roberfroid, 1995). According to Gibson (2001), prebiotic oligosaccharides produce subordinate 
health beneficial effects: improved tolerance to lactose due to the presence of lactase, protection from 
gastroenteritis by the excretion of antimicrobial substances or competition for colonization sites and 
nutrients, prevention of bowel cancer and coronary heart disease, vitamin B synthesis, and decreased 
carcinogenesis from digestion contents by reducing enzyme levels for β-glucuronidase, β-glucosidase, 
nitroreductase and urease in intestinal flora.  
3.2.1.3. Low Cariogenic Property 
Biosynthesis of extracellular water insoluble glucans (mutan) from sucrose facilitates the 
accumulation of oral streptococci such as S. mutans, S. sobrius, and S. sanguis, and increases the cellular 
adhesion and serves as a matrix for plaque formation (Michalek and Childers, 1990; Walker, 1972; 
Guggenheim and Newbrun, 1969). This process results ultimately in dental caries (Lee 2005; Rolla et al., 
1983). Some oligosaccharides are useful in preventing dental plaque. Cariogenic oligosaccharides, such 
as maltooligosylsucrose known as coupling sugar, and palatinose (6-O-α-D-glucosyl-D-fructofranose: 
isomalturose) inhibit the production of insoluble glucans and fatty acids because they are not 
metabolized by the oral streptococci (Ooshima et al., 1983; Otaka, 2006). 
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3.2.2. Anti-fungal Agents 
Antifungal agents are compounds that selectively eliminate fungal pathogens from a host, with 
minimal toxicity to the host (Dixon and Walsh, 1996). Control of fungi is crucial to prevent losses in 
food supplies and to decrease the fatal effects of fungal infections in people with weakened immune 
systems (Groll et al., 1998; Georgopapadakou and Tkacz, 1995). Studies of antifungal agents have 
lagged behind research on antibacterial agents (Ghannoum and Rice, 1999). Bacteria are prokaryotic and 
offer numerous structural and metabolic targets that differ from those in human hosts. However, fungi 
are eukaryotic with the same biochemistry as mammalian cells resulting in many similarities between 
fungi and host cells in both cell structure and metabolism. Due to these similarities, many antifungal 
agents can be toxic to host cells as well as fungi. This causes toxic side effects on exposure to antifungal 
agents. There is a lack of selective toxicity of antifungal agents producing a poor selection of clinically 
available drugs (Abu-Elteen and Hamad, 2005). Poor solubility of many antifungal agents and poor 
absorption through the gastrointestinal tract reduce feasibility of oral administration and increase the 
levels of toxicity associated with the use of antifungal agents (Abu-Elteen and Hamad, 2005). Antifungal 
agents are usually classified into three major groups by their site of action: antimicrobial agents affecting 
fungal sterols, compounds inhibiting nucleic acids, and compounds active against fungal cell walls 
(Ghannoum and Rice, 1999). 
3.2.2.1. Currently Used Antifungal Agents 
3.2.2.1.1. Antimicrobial Affecting Fungal Sterols 
 Antifungal agents such as azoles, polyenes, and allylamine/thiocarbamates can inhibit synthesis 
or interact with ergosterol (Parks and Casey, 1996). Ergosterol is the predominant component of fungal 
cell membrane and acts as a bio-regulator of membrane integrity controlling membrane fluidity and 
asymmetry (Nozawa and Morita, 1986).  
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Azole antifungal agents generally have five-membered rings containing either two or three 
nitrogen molecules-imidazole and trizoles (Holt, 1980). The heme protein, the primary target of azoles, 
catalyzes cytochrome P-450-dependent 14α-demethylase. The enzyme controls depletion of ergosterol 
and accumulation of sterol precursors including 14α-methylated sterols (lanosterol, 4, 14-
dimethylzymosterol, and 24-methylenedihydrolanosterol). Blocking this enzyme may result in the 
formation of a plasma membrane with altered structure and function (Sanati et al., 1997; Hitchcock et al., 
1990). However, long-term use of azoles can cause liver toxicity (Parks and Casey, 1996). Moreover, 
the use of azoles-fluconazole, ketoconazole and miconasol has been reported to be clinically resistant by 
Candida spp. (Lyman and Walsh, 1992; Sojakova et al., 2004).  
 Polyene is called a large macrolide ring closed by the formation of an internal ester of lactone 
(Abu-Elteen and Hamad, 2005). Amphotericin B, nystatin, and flucytosine are widely used polyene 
antifungal agents. Amphotericin B is considered to be the “gold standard” for antifungal drugs. However, 
its use is limited due to infusion related reactions and nephrotoxicity (Fanos and Cataldi, 2000). Polyene 
increases cell membrane permeability, which leads to leakage of cellular constituents (amino acids, 
sugars and other metabolites), resulting in cell lysis and death. The polyene compounds interact with 
sterols in cell membranes, ergosterol in fungal cells or cholesterol in human cells to form channels 
through the membrane that cause the cells to become leaky (Parks and Casey, 1996). 
 Allylamine inhibits the enzyme squalene epoxidase in the fungal biosynthesis of ergosterol 
(Katz, 1999), and is used for the treatment of superficial dermatophytic and yeast infections (Perez, 
1999).  
3.2.2.1.2. Compounds Inhibiting 	ucleic Acids 
The compound that disrupts nucleic acids is 5-fluorocytosine, a fluorinated pyrimidine. Once 5-
fluorocytosine enters fungal cells aided by a permease, it is converted to 5-fluorouracil by cytosine 
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deaminase. The 5-fluorouracil is subsequently converted by UMP pyrophosphorylase into 5-
fluorouridylic acid (FUMP), phosphorylated further and incorporated into RNA, resulting in disruption 
of protein synthesis (Polak and Scholer, 1975). The 5-fluorouracil is also converted to 5-
fluorodeosyuridine monophosphate, a potent inhibitor of thymidylate synthase, an enzyme involved in 
DNA synthesis and nuclear division. Therefore, 5-fluorocytosine can interfere with pyrimidine 
metabolism, as well as RNA, DNA, and protein synthesis in fungal cells (Diasio and Myers, 1978).  
3.2.2.1.3. Compounds Active against Fungal Cell Walls 
The fungal cell wall is a multilayered structure composed of chitin, β-glucan and mannan, which 
is not replicated elsewhere in nature. The outer layers are composed of mannan, mannoprotein, β-(1,6)-
glucan, whereas the inner layers are predominantly β-(1,3)-glucan and chitin with some mannoprotein 
(Hector, 1993).  
3.2.2.1.3.1. Chitin Synthesis Inhibitors 
 Chitin is a long linear homopolymer of β-1,4-linked .-acetylglucosamine which constitutes 1-2 % 
of the yeast cell wall and 10-20% of the cell walls of filamentous fungi, .eurospora and Aspergillus, by 
dry weight (Bowman and Free, 2006; De Nobel et al., 2000; Klis et al., 2002). Despite being a minor 
component in the fungal cell wall, its structure is pivotal to the overall integrity of the cell wall and its 
enormous tensile strength (Bowman and Free, 2006). Without chitin, the cell wall becomes disordered, 
mal-formed and osmotically unstable, leading to cell death (Bago et al., 1996; Specht et al., 1996). 
Chitin synthase catalyzes the transfer of .-acetly glucosamine from uridine diphosphate (UDP)-.-
acetylglucosamine to a growing chitin chain (Bowman and Free, 2006). At sites of active growth and 
cell wall remodeling, hydrogen bondings between the newly formed chitin polymers form chitin 
microfibrils and subsequently crystallize chitin in the extracellular space immediately adjacent to the 
plasma membrane. In yeast cells, this process occurs at the bud tips during polarized growth and the bud 
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neck during cytokinesis. For filamentous fungi, cell wall synthesis localizes at the hyphal apex or the 
growing tips (Bowman and Free, 2006). The best chitin synthesis inhibitors are nikkomycins, 
demethylallosamidin, and polyxins (Bowman and Free, 2006; Abu-Elteen and Hamad, 2005). These 
agents function as mimics or decoys of the enzyme substrate UDP-.-acetylglucosamine for chitin 
synthase (Abu-Elteen and Hamad, 2006; Hector, 1993). However, their effectiveness to control mycoses 
has not been proved. Combined treatments using nikkomycins and fluconazole and itraconazole have 
often been used (Abu-Elteen and Hamad, 2006; Bowman and Free, 2006).  
3.2.2.1.3.2. Glucan Synthesis Inhibitors 
 The fungal cell wall contains approximately 50-60% glucans. A β-(1,3)-glucan is the major 
structural constituent (65-90%) in the fungal cell wall (Bernard and Latge, 2001; Klis et al., 2001). The 
cell walls of S. cerevisiae and C. albicans contain branched β-(1,3)- and β-(1,6)-glucans (Cabib et al., 
1988) whereas the cell walls of many filamentous fungi including .eurospora crasssa and A. fumigates 
contain only β-(1,3)-glucan (Borkovich et al. 2004; Fontaine et al., 2000).  
The multisubunit enzyme, β-1,3-D-glucan synthase (1,3-β-D-glucan 3-β-D-glucosyltransferase; 
EC 2.4.1.34; GS) catalyzes the formation of long linear chains of glucans connected through  β-1,3-
linkages from UDP-glucose (UDPG) (Cabib et al., 1988). A genetic study of β-1,3-D-glucan synthase in 
S. cerevisiae identified that the gene contains two functionally redundant catalytic subunits-FKS1 and 
FKS2 and one regulatory protein-RHO1 (Douglas et al., 1994; Mazur et al., 1995; Qadota et al., 1996). 
Fks1p is the major protein responsible for GS activity during vegetative growth whereas Fks2p appears 
to be important for sporulation (Marzur et al., 1995). The activation and the movement of Fks1p to the 
plasma membrane are required for cell wall β-1,3 glucan synthesis and have been shown in many fungi 
including Schizosaccharomyces pombe and Aspergillus species (Lesage and Bussey, 2006). When FKS1 
is disrupted, the strains are viable but decrease the β-1,3-D-glucan synthase activity by 5-8 fold and are 
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three fold more sensitive to pneumocandin (Douglas et al., 1994). Disruption of FKS2 is not lethal. 
However, simultaneous deletion of FKS1 and FKS2 is lethal, suggesting that they encode 
interchangeable subunits of β-1,3-D-glucan synthase with common functions (Douglas et al., 1994; 
Mazur et al., 1995). S. cerevisiae RHO1 gene is essential for survival. The FKS and RHO1 genes are 
also highly conserved among fungi and required for cell viability (Bowman and Free, 2006; Beauvais et 
al., 2001).  
 The β-glucan synthase inhibitors, especially echinocandins, act as specific noncompetitive 
inhibitors of β-(1,3)-glucan synthase (Hector, 1993) without affecting nucleic acid or mannan synthesis. 
These inhibitors also have secondary effects on other components of intact cells including a reduction in 
the ergosterol and lanosterol and an increase in the chitin in the cell (Pfaller, 1989). Use of capsofungin, 
the first clinically used echinocandin, and other echinocandins produce changes in filamentous fungal 
growth, morphology and cell wall structure of the hyphae (Kurtz et al., 1994) since the FKS genes 
localize at the hyphal apex (Beauvais et al., 2001; Douglas et al., 1994). This is supported by 
observations that a 1,3-β-D-glucan-specific fluorochrome stained cell has the most intense fluorescence 
at the hyphal apex and a new cell wall was formed exclusively at the hyphal apices in A. nidulans 
(Momany et al., 1999). Therefore, inhibition of β-(1,3)-glucan synthase causes cytological and 
ultrastructural changes in fungi characterized by growth of pseudohyphae, swollen hyphae, thickened 
cell wall, or buds failing to separate from mother cells. Cells become osmotically sensitive to lysis 
which is restricted largely to the growing tips of budding cells (Bozzola et al., 1984; Cassone et al., 
1981).  
3.2.2.2. Other Potential Antifungal Agents 
Danac et al. (2007) attempted to inhibit chitin biosynthesis using selectively functionalized 
β(1→4).-acetylglucosamine (GlcNAc) at C-4. According to the hypothesis of Danac et al. (2007), a 
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chain terminator, GlcNAc residue with modified 4-hydroxyl might lead to a chitin chain-termination 
step since the required 4-hydroxyl, at which subsequent units would had been added, would then be 
absent. They found that GlcNAc-derived ester and oxazoline having N3 at C4 interfered with adhesion 
and germination of the dermatophyte, Trichophyton rubrum (Danac et al., 2007).  
 According to Bisogno et al. (2007), cinnamic acid derivatives, more specifically (E)-3-4-
[methoxy-3-(3-methylbut-2-enyl) phenyl] acrylic acid exhibited antifungal activity against A. niger, A. 
flavus, and A. terreus. They also investigated the relationship between the structure of cinnamic acid 
derivatives and antifungal activity. The absence of the double bond of the side chain in cinnamic acid 
derivatives did not affect fungal growth. They concluded that the presence of the double bond confers a 
particular conformational and electronic characteristic to these compounds. A COOH group in the side 
chain of these compounds seemed to be necessary, but not by itself sufficient to produce antifungal 
potency.  
A peptide, Ay-AMP, isolated from Amaranthus hypochondriacus seeds has a chitin-binding 
property and inhibited the fungal growth in C. albicans, Trichoderma sp., Fusarium solani, Penicillium 
chrysogenum, Geotrichum candidum, A. candidus, A. schraceus, and Alternaria alternate (Rivillas-
Acevedo and Soriano-Garcia, 2007). This peptide settled along the fungal cell walls and accumulated at 
septa and hyphal tips by the union to the fungus cell-wall chitin.  
Zumbuehl et al. (2007) found that amphogel, a dextran-based hydrogel into which amphotericin 
B (AmB) is absorbed, killed C. albicans within two hours of inoculation and it effectiveness was 
maintained for at least 53 days. The dextran could be a protein repellent (Frazie et al., 2000) and 
mitigate biofilm formation (Verstrepen et al., 2004), and gave AmB a hydrophilic matrix (Zumbuehl et 
al., 2007). This hydrogel was biocompatible and did not cause hemolysis in human blood.  
The steroid saponins have been reported as antifungal agents in many literatures (Zhang et al., 
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2006; Ekabo et al., 1996: Mshvildadze et al., 2000; Renault et al., 2003; Sautour et al., 2004). Zhang et 
al. (2006) concluded a spirostanol framework with a number of oligosaccharide residue attached at the 
C-3 of the aglycon might closely relate to the antifungal efficacy of steroid saponins. However, a steroid 
saponin without a carbonyl base at C-12 (Zhang et al., 2006) and furostanol-type steroidal glycoside 
(Hufford et al., 1988) did not have antifungal activity.  
Lactic acid bacteria metabolites such as organic acids, fatty acids, and cyclic dipeptide have 
been exploited as antifungal agents (Valerio et al., 2004; Magnusson et al., 2003; Lavermicocca et al., 
2000). Phenyllactic and 4-hydroxy-phenyllactic acids effectively inhibited the growth of A. niger, A. 
flavus, Eurotium rubrum, E. repens, E. fibuliger, Penicillium corylophilum, P. roqueforti, and Monilia 
sitophila (Valerio et al., 2004; Lavermicocca et al., 2000). Some cyclo peptides: cyclo(L-Phe-L-Pro), 
cyclo(L-Phe-trans-4-OH-L-Pro), and cyclo (Phe-Pro), and cyclo(Phe-4-OH-Pro) isolated from lactic acid 
bacteria showed antifungal activity (Ström et al., 2002; Magnusson et al., 2003). According to Cabo et al. 
(2002), the synergism between lactic acid produced from lactic acid bacteria and acetic acid from the 
MRS growth medium showed strong antifungal activity. However, Magnusson et al. (2003) negated the 
possibility that the degree of fungal inhibition related to production of lactic or acetic acid as changes in 
organic acid concentrations did not explain the varying degrees of inhibition of fungi. They suggested 
that lactic acid bacteria from different genera and species, even different environments can exhibit 
antifungal activity producing several different compounds and proposed more study on compounds and 
action modes.  
We have verified the potential of cellobio-oligosaccharides as an anticariogenic agent and an α-
glucosidase inhibitor. It is possible that these cellobio-oligosaccharides may be a potential antifungal 




3.3. MATERIALS A	D METHODS 
3.3.1. Cariogenicity 
3.3.1.1. Microorganisms and Isolation of Mutansucrase 
 Oral bacteria used were collected by a cotton swab from teeth and streaked onto a brain heart 
infusion (BHI) agar containing 4% sucrose. They were grown at 37°C until visible colonies of 
Streptococcus mutans and S. sorbrinus appeared. The colonies were grown in 1 L BHI at 37°C with 
shaking at 150 rpm for 24-36 hours to produce mutansucrase. After fermentation, the culture was 
harvested, centrifuged and concentrated to 100 ml using a 30 K cut-off membrane filter. One unit of 
mutansucrase was defined as the amount of enzyme that catalyzes the formation of 1 µmol of fructose 
per minute at 37°C and pH 7.0 from 100 mM sucrose.  
3.3.1.2. Inhibition of Mutansucrase and Insoluble Glucan Synthesis 
 The inhibition of CBO on the synthesis of water insoluble glucans by oral Streptococcus species 
and mutansucrase was determined. Streptococcus species were inoculated in 2x BHI broth containing 
1M sucrose and 50 mM CBO and were cultured in glass vials at 37°C for 48 hours. Mutansucrase was 
incubated in 20 mM HEPES (pH 7.0) containing 1 M sucrose and 50 mM CBO in glass vials at 37°C for 
48 hours. The supernatants of individual reaction mixtures were discarded and insoluble glucans 
remained in the vial. For comparison of the amount of insoluble glucans produced, the synthesized 
glucans were washed with a 20 mM .-2-hydroxyethylpiperazine-.’-2-ethanesulfonic acid (HEPES; pH 
7.0) and dissolved in 0.5 N NaOH. The absorbance of water insoluble glucans was measured at 550 nm 
(Lee et al., 2003). For visualization, synthesized glucans were dyed with a drop of dental disclosing 
solution.  
3.3.2. α-Glucosidase Assay 
Enzyme reaction mixtures contained 4.9 U α-glucosidase, 88 mM maltose, and different 
concentrations of cellobio-oligosaccharides (0-3.3 mM) in 20 mM HEPES buffer (pH 7.0) and were 
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incubated for 90 minutes at 25˚C. α-Glucosidase (maltase) activity was assayed according to the method 
of glucose oxidase-peroxidase using a glucose assay kit (Sigma-Aldrich, St. Louis). Glucose was used as 
a standard curve. The color developed final product (oxidized o-dianisidine) was measured at 540 nm.  
3.3.3. Antifugal Effect 
3.3.3.1. Microorganism and Culture Condition 
A. terreus was maintained on potato dextrose agar (PDA) medium for 5 to 7 days at 28°C. 
Conidia were collected with a cotton swab and suspended in 0.9% NaCl solution with 0.05% Tween 20. 
The heavy particles were allowed to settle for 2 hours in cold (4˚C) solution. For the effect of CBO on 
the growth of A. terreus, 2.5 x 104 conidia were inoculated into 2.9 ml of potato dextrose broth (PDB) 
with CBO and incubated for 10 days at 28˚C.  
3.3.3.2. Preparation of (1,3)-β-D-Glucan Synthase 
For glucansynthase production, 4.5 x 108 conidia were inoculated into 500 ml of YME medium 
containing 0.4% yeast extract, 1.0% malt extract, and 0.4% dextrose and incubated at room temperature 
for 1 to 2 days with shaking at 150 rpm. The spherical mycelia grown on YME medium with shaking 
were harvested by centrifugation at 1,500 x g for 10 minutes. Cells were washed extensively with water 
and then centrifuged at 1,500 x g for 10 minutes. Cell breakage was performed using 20 cycles (1 min 
each) of vortexing with prechilled glass beads in chilled extraction buffer containing 50 mM HEPES 
(pH 7.2), 1 mM EDTA, 1 mM dithiothreitol (DTT), 10% glycerol, 1 µg of leupeptin per ml, and 10 µM 
GTPrS at approximately 5 ml of buffer per cell (g, wet weight). Cells were cooled for 5 minutes on ice 
between cycles. The homogenate was centrifuged at 1,500 x g for 10 minutes to remove cell debris. 
After centrifugation at 23,000 x g for 10 minutes to remove mitochondrial membranes, the supernatant 
was ultra-centrifuged at 100,000 x g for 1 hour to recover microsomal membranes in a pellet. This pellet 
was resuspended in one-tenth the original volume of cold storage buffer containing 50 mM HEPES (pH 
113 
 
7.2), 1 mM EDTA, 1 mM DTT, and 20% glycerol. Protein concentration of isolated (1,3)-β-glucan 
synthase was 2.5 mg/ml. All procedures for enzyme preparation were carried out at 4°C. Protein 
concentration was determined by the method of Bradford with Bio-Rad reagent and bovine serum 
albumin was used as standard. 
3.3.3.3. Assay of (1,3)-β-D-Glucan Synthase 
 Glucan synthase activity was determined by the modification of a fluorescence method (Ko and 
Cheng, 2005; Shedletzky et al., 1997). The assay mixture (150 µl) contained 27 mM HEPES (pH 7.2), 7 
µM GTP, 1.3 mM EDTA, 0.17% Brij 35, 2.2% glycerol, 0.7 mM UDP-Glc, and isolated GS enzyme 
(0.83 µg/µl). For inhibition studies, 0.12-0.63 µg of CBO were added to the desired mixture. Reactions 
were started by addition of GS, incubated at 22°C for 105 minutes, and terminated by an addition of 10 
µl of 6 N NaOH. Glucans produced were solublized in a water bath at 80°C for 30 minutes followed by 
addition of 20 µl of one forth diluted SirofluorTM(Biosupplies, Australia). The mixtures were incubated 
for 50 minutes at 22°C and measured with a fluorescence spectrophotometer (FluoroLog) at an 
excitation wavelength of 390 nm and an emission wavelength of 455 nm. Standard curves were 
constructed using various concentrations of yeast glucan, dissolved in 300 µl of 1 N NaOH by heating 
30 minutes at 80°C, containing the same components as the reaction mixtures except enzyme. 
3.3.3.4. Electron Microscopy 
A study of the morphologic aspects was conducted by scanning electron microscopy (SEM; 
Nishiyama et al, 2005). Conidia (3.0 x 104) were inoculated in PDB and incubated at 28°C. After 16 
hour incubation, CBO was added to a test tube and H2O into a second tube as a control. They were 
further incubated for two days at 28°C. For SEM, cultures were fixed with 2% glutaraldehyde in 0.1 M 
cacodylate buffer (pH 7.2) at 4°C for 2 hours. After being washed with the buffer, specimens were post-
fixed for 2 hours with 1% osmium tetroxide in 0.1 M cacodylate buffer (pH 7.4) at 4°C. Samples were 
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dehydrated in graded acetone, freeze-dried in t-butyl alcohol and sputter–coated with palladium-gold. 
Observation was carried out with a scanning electron microscope (Nishiyama et al., 2001).  
3.4. RESULTS A	D DISCUSSIO	 
3.4.1. Cariogenicity 
The CBO inhibited effectively the synthesis of water insoluble glucans in the presence of 
sucrose by mutansucrase (Figure 3.1). In the presence of 50 mM CBO and 1 M sucrose, only 4% of 
insoluble glucans were produced compared to that of 1 M sucrose reaction mixture. Cellobiose (50 mM) 
did not affect insoluble glucan formation as almost same amount of insoluble glucans was produced as 
in the control. Insoluble glucans in solution were swirled along the inner layer of a glass vial, and the 
liquid discarded. Then the carbohydrates were dyed with a dental disclosing solution. The insoluble 
glucans adhered as an inner layer on a glass vial as dental plaque does on teeth (Figure 3.2). The 
quantity of insoluble glucans adhered to a glass was less for the CBO mixture than the control or 
cellobiose test. The inhibitory effect of CBO against mutansucrase might be caused by an acceptor 
reaction of glucosyltransferase, leading to termination of glucan synthesis from sucrose. Our data are 
consistent to that observed with isomaltosylfructoside (Nisizawa et al., 1986), fructosylxyloside (Takeda 
and Kinosh, 1995), maltosylsucrose (Lee et al., 2003), glucooligosaccharides and fructooligosaccharides 
(Nam et al., 2007). Dental caries is mostly caused by S. mutans and S. sobrinus which synthesize 
extracellular water insoluble glucans from sucrose by glucosyl transferase (Hamada and Slade, 1980). 
The insoluble glucans become plaque on teeth and result in tooth decay. In addition, S. mutans and S. 
sobrinus synthesize intracellular polysaccharides as carbohydrate reserves, which can be converted to 
acids when dietary carbohydrates are available (Marsh, 1999). CBO has a potential to become an active 






Figure 3.1. Effect of addition of cellobiose or CBO on the formation of insoluble glucan by 
mutansucrase. Relative amount of insoluble glucans is the percent of the amount of insoluble glucans 




















































B.     
Figure 3.2. Insoluble glucans synthesized under different conditions in glass vials. 
addition of disclosing solutions; Panel B and C, after addition of disclosing solutions. Insoluble glucans 
were synthesized for 48 hours at 37 °C by mutansucrase in the presence of 1 M 











Panel A, before 




3.4.2. α-Glucosidase Inhibition 
The inhibitory activity of CBO against α-glucosidase (Figure 3.3) was determined. Increased 
concentrations of CBO decreased the amount of glucose produced from maltose by α-glucosidase.  
α-Glucosidase activity was 86% of control in the presence of 0.7 mM CBO, 77% in the 
presence of 2.0 mM CBO, and 55% in the presence of 3.3 mM CBO. Inhibition of α-glucosidase can 
delay carbohydrate digestion and glucose absorption, attenuating postprandial hyperglycemia (Bischoff, 
1995; Lee, 2005; Truscheit et al., 1981). At present, α-glucosidase inhibitors such as acarbose, miglitol, 
and voglibose are commonly used to reduce the postprandial hyperglycemia by interfering with the 
digestion of dietary carbohydrates (Moordian and Thurman, 1999; Williamson et al., 1992). Acarbose is 
widely used as a therapeuctic agent for the treatment of patients with type II diabetes mellitus (Chiasson 
et al., 2002; Balfour, 1993). Concern about its side effects is driving the search for alternative safe and 
efficient α-glucosidase inhibitors (Matsuura et al., 2002).  
3.4.3. Antifungal Effect 
3.4.3.1. Inhibition against Glucan Synthase 
Antifungal agents, the GS inhibitors have been validated as an effective treatment of fungal 
infections because these agents inhibit fungal cell wall synthesis, a target unique to lower eukaryotes 
(Onishi et al, 2000). The effect of CBO on GS, the essential enzyme that forms β-(1,3)-glucan fibrils 
from UDP-glucose, was evaluated. Inhibition was largely dose dependent (Figure 3.4). The 
concentration of 0.12 g/ml CBO was not sufficient to inhibit GS activity. The 50% inhibitory 
concentration (IC50) for CBO was 0.36 g/ml.  
The role of CBO on GS was further evaluated by a kinetic study over a range of concentrations 
of UDP-glucose ranging from 0.05 to 8 mM with CBO added at concentrations of 0, 0.24, and 0.36 g/ml.  







Figure 3.3. Inhibition effect of CBO against α-glucosidase. The reaction mixture contained 4.9 U α-
glucosidase, 88 mM maltose, and different concentration of cellobio-oligosaccharides (0, 0.7, 2.0, and 
3.3 mM) in 20 mM HEPES buffer and incubated for 90 min at 25˚C. Error bars show the standard 



































Figure 3.4. Inhibition of glucan synthase activity by cellobio-oligosaccharides. Relative activity is 
the percent of 1,3-β-D-glucan synthase acitivity (GS) at test concentration of cellobio-oligosaccharides 
(CBO) to the GS activity at none CBO added reaction mixture (control). For the determination of GS 
activity, 0.7 mM UDP-G was reacted with 0.83 µg/µl GS in 27 mM HEPES (pH 7.2) containing 7 µM 
GTP, 1.3 mM EDTA, 0.17% Brij 35, and 2.2% glycerol in the addition of 0, 0.12, 0.24, 0.36, and 0.48 
g/ml CBO at 22°C for 105 min. A SirofluorTM binding with 1,3-β-D-glucans was then conducted as 
described in the material and method section. The fluorescence was measured excitation wavelength of 




































three oligosaccharide concentrations are illustrated in Figure 3.5. The non-parallel lines which converge 
at x<0 and y>0 are consistent with mixed type of inhibition.  
There are no reports on the relationship of oligosaccharides containing mixed β(1→4), α(1→2), 
and α(1→6) linkages and fungal glucan synthases. A cellotriose, comprising glucose linked with only β-
1,4, enhanced glucan synthase isolated from Euglena gracilis (Marechal and Goldemberg, 1964).  
Differences between our CBO and this cellotriose (Marechal and Goldemberg, 1964) demonstrate that 
the type of linkages may be important in altering glucan synthase activity. Cellobiose has been reported 
to be a stimulator for glucan synthase production in sugar beet (Morrow and Lucas, 1986) and Euglena 
gracilis (Marechal and Goldemberg, 1964). However, cellobiose does not stimulate the glucan synthase 
of S. cerevisiae (Lopez-Romero and Ruiz-Herrera, 1978) and the germinating peanut, Arachis hypogaea 
(Kamat et al., 1992). A very simple sugar based chemical, δ-gluconolactone was an effective inhibitor of 
(1→3)-β-D-glucan synthase in the sugar beet (Morrow and Lucas, 1987) and in S. cerevisiae (Lopez-
Romero and Ruiz-Herrera, 1978).  
So far, most GS inhibitors have been categorized in three chemical classes of compounds-
lipopeptides comprising cyclic hexapeptides .-linked to a fatty acyl side chain, papulacandins 
consisting of a modified disaccharide linked to two fatty acyl chains, and acidic terpenoids (Douglas, 
2001; Onishi et al., 2000; Tracz 1992; Traxler et al., 1977).  
3.4.3.2. Morphological Changes in Aspergillus terreus 
Most glucan synthase inhibitors induce profound morphological changes in fungal hyphae 
which correlate with inhibition of glucan synthase (Kurtz et al., 1994; Bozzola et al., 1984; Cassone et 
al., 1981). Observation of hyphal changes after addition of CBO was conducted using SEM. Hyphae of 
A. terreus showed distinct structural differences between control and CBO treated cultures (Figure 3.6). 





Figure 3.5. Lineweaver-Burk plot: inhibition of (1→3)-β-D-glucan synthase by cellobio-
oligosaccharide. The assay mixtures contained 27 mM HEPES (pH 7.2), 7 µM GTP, 1.3 mM EDTA, 
0.17% Brij 35, and 2.2% glycerol, varying concentration of UDP-G (0.05, 0.25, 0.5, 1.0, 2.0, 4.0, 6.0, 
and 8.0 µg/µl) also containing 0.83 µg/µl 1,3-β-D-glucan synthase (GS). The reaction allowed to react for 
105 min at 22°C. GS activity was also measured in the absence or presence of 0, 0.24, and 0.36 g/ml 
cellobio-oligosaccharides. A SirofluorTM binding with 1,3-β-D-glucans was then conducted as described 
in the material and method section. The fluorescence was measured excitation wavelength of 390 nm 





























CBO treated A. terreus failed to bud their cells, and the population did not increase. In addition, their 
widths of hyphae were different between the two cultures when 20 hyphae were randomly selected and 
measured. The average width (3.4 µm) of twenty hyphae in CBO treated A. terreus was 1.35 fold larger 
than that (2.5 µm) in the control. In the presence of CBO, the cells grew with swollen hyphae, indicating 
inhibition of glucan synthesis (Kurtz et al., 1994). This observation supports the fact that glucan 
synthesis inhibition produces stunted, swollen hyphae, caused from a weakened cell wall that expands 
under high internal pressure (Onishi et al., 2000). In the work of Kurtz et al. (1994), pneumocandin 
treated A. fumigates caused swelling and distension of the hyphae. Although the abundance of 1,3-β-D-
glucans in the cell walls formed during different stages of the A. fumigatus life cycle is not well 
characterized, the focus of new cell wall synthesis is the hyphae during vegetative growth (Archer, 1977; 
Beauvais et al., 2001: Ruiz-Herrera, 1992), and inhibition of 1,3-β-D-glucan synthesis has profound 
effects on cell wall structure in A. fumigatus (Kurtz et al., 1994). Inhibition of glucan synthesis results in 
structural changes, characterized as pseudohyphae, swollen hyphae, thickened cell wall, or buds failing 
to separate from mother cells (Kurtz et al., 1994; Bozzola et al., 1984; Cassone et al., 1981). We 
explored the effect of CBO on A. terreus, grown in PDB and PDA during extended incubation up to ten 
days at 28˚C (Figure 3.7). When A. terreus was grown in PDB medium, it formed tangled hyphal masses 
on the surface in a tube. However, they were not observed when A. terreus was incubated with CBO in 
PDB medium. There was substantial growth in the untreated culture during the course of the experiment.  
 There is no comparable data that oligosaccharide alone works as an antifungal. Almost all 
proposed antifungal agents have complicated structures. Nevertheless, Kaur et al. (2006) suggested that 
a small and simple sugar acid, D-gluconic acid from Pseudomonas strain AN5 may have antifungal 
activites against take-all disease of wheat caused by Gaeumannomyces graminis var. tritici. Some 





Figure 3.6. Scanning Electron Microscopy (SEM) images of 
growth of cells (no cellobio-oligosaccharide); B, growth of cells treated with cellobio
















Figure 3.7. In vitro growth of A. terreus
growth of cells treated with cellobio
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 in PDB and PDA. Panels: A, control growth of cells; B, 




cellobiose-lipids of yeast fungi Cryptococcus humicola and Pseudozyma fusiformata (ustilagic acid B) 
inhibited the growth of a number of species important for medicine: Candida. albicans, C. glabrata,  
C. viswanathii, F. neoformans, and Clavispora lusitaninae (Kulakovskaya et al., 2007; Kulakovskaya et 
al., 2006). They may stimulate the release of ATP from the test culture cells, indicating an increase the 
permeability of the plasma membrane, and resulting in cell death (Puchkov et al., 2001; Kulakovskaya et 
al., 2004). Mimee et al. (2005) isolated Flocculosin, a low molecular weight cellobiose-lipid, from the 
yeast like fungus Pseudozyma flocculosa to investigate antifungal activity. Flocculosin significantly 
inhibited the growth of Candida lustitaniae, C. neoformans, Trichosporon asahii, and C. albicans. 
Synergistic activity was also verified between flocculosin and amphotericin B, suggesting the potential 
for amphotericin B having much lower MIC. Most isolated cellobiose-lipids have considerable efficacy 
as potential antifungal agents under acidic conditions (Kulakovskaya et al., 2007; Mimee et al., 2005).  
Based on our data, CBO has a great potential to function as a new class of antifungal agent 
against fungi which correlate with 1,3-β-D-glucan synthase inhibition.  
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CHAPTER 4. CO	CLUSIO	S 
 The utilization of cellulose has attracted much attention because of its potential as a feedstock 
for bioethanol production. The economics of bioethanol production requires large volumes of product at 
a low cost. For a “biorefinery” to be economically viable, it should produce a range of products, not just 
bioethanol. Current research has focused on biofuel production and a potentially valuable product, 
cellobiose has been overlooked. This research has focused on a developing technologie(s) where 
lignocellulose conversion can be modified such that cellobiose and other oligomers are produced as 
products. The inhibition of cellulase by glucose degradation products-gluconolactone and gluconic acid 
has been previously reported (Holtzapple et al 1990; Philippidis et al 1993). However, thought has not 
been given to use cellulase inhibition to increase cellobiose concentrations. The inhibitors-glucose 
oxidase, gluconic acid, and gluconolactone inhibited selectively the β-glucosidase associated with the  
cellulase “complex”, since they produced equivalent (in the presence of glucose oxdase and 
gluconolactone) or similar (in gluconic acid) inhibition on either pure β-glucosidase or β-glucosidase in 
the cellulase “complex”. Our inhibition studies agree with others (Dixon et al., 1979; Holtzapple et al., 
1990) in that both gluconolactone and gluconic acid exhibit mixed inhibition. Box-Behnken data 
demonstrated that cellobiose production was largely dependent on the concentrations and combination 
of cellulose as a substrate, cellulase, inhibitor, and reaction time as well as the type of inhibitor. 
Ammonia treated sugarcane bagasse used as a substrate in these reactions, produced cellobiose in the 
same manner as pure cellulose, although cellobiose yields from ammonia treated sugarcane bagasse 
were lower than with pure cellulose, probably due to the presence of “undesired” components in the 
hydrolysis system. Mixtures of cellulase and any of the test inhibitors produced between 7.4-10.4 times 
more cellobiose than cellulase in the absence of inhibitor(s). Gluconolactone was the most effective β-
glucosidase inhibitor for producing 31.2% cellobiose of complete conversion of cellulose to cellobiose. 
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The yield of cellobiose was 23.7% with glucose oxidase, similar to 21.9% with an oxidized product of 
glucose, gluconic acid. Cellobiose produced using this cellulase modification system is significantly 
higher than has been previously achieved, yields between 0.07 and 7.5% (Homma et al., 1993; Tanaka, 
2000; Tanaka and Oi, 1985). If there is a market for cellobiose, significant quantitites could be produced 
by this method to produce an additional product from a biorefinery.  
 Dextransucrase from Leuconostoc mesenteroides B-512FMCM was used to synthesize, by 
transglycosylation, cellobio-oligosaccharides from sucrose and cellobiose. Enzymatic transglycosylation 
for oligosaccharide synthesis has advantages in time-, cost-, and process step-effectiveness over either a 
Leloir synthesis which requires sugar nucleotides as a glucosyl donor or chemical methods (Nahalka et 
al., 2003).  Dextransucrase was produced free of dextran and sucrose phosphorylase which could affect 
transglycosylation efficiency.  The reaction for transglycosylation of sucrose onto cellobiose to produce 
oligosaccharides was conducted at a pH of 5.2 and a temperature of 30˚C. The concentration of 
dextransucrase was 54 U, the concentration of sucrose was 289 mM and the concentration of cellobiose 
was 250 mM. The cellobio-oligosaccharide yield reached 20% based on initial cellobiose concentrations. 
This process required few steps to obtain final products. They are the transglycosylation reaction of 
cellobiose and sucrose; dextran removal by ethanol precipitation; concentration; and chromatographic 
purification of product. The synthesized cellobio-oligosaccharides ranged in size from DP 3 to 6. The 
major products were trisaccharides. Their proposed structures are α-D-glucopyranosyl-(1→2)-β-D-
glucopyranosyl-(1→4)-D-glucopyranose and α-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl-(1→4)-
D-glucopyranose.  
 These cellobio-oligosaccharides were found to inhibit synthesis of the water-insoluble glucans 
that are related to dental caries occurrence and the α-glucosidase activity involved in the final step of 
carbohydrate digestion. This potential anticariogenic function of cellobio-oligosaccharides could be used 
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in conjunction with dietary sweeteners and soft drinks in the food industry and toothpaste and related 
products in pharmaceutical industries. The finding that cellobio-oligosaccharides are potential inhibitors 
of α-glucosidase suggests utilization as dietary supplements or drugs for diabetes mellitus and obesity. In 
addition to these functions, an in vitro β-1,3-D-glucan synthase test and a cell morphology phenomenon 
indicate the inhibition effects of cellobio-oligosaccharides on fungal cells. The cellobio-oligosaccharides 
inhibited β-1,3-D-glucan synthase as a mixed type of inhibition. Moreover, cellobio-oligosaccharides 
treated A. terreus grew with swollen hyphae. They have supported the idea that cellobio-
oligosaccharides inhibit the growth of Aspergillus terreus (and possibly other fungi imperfecti) by 
inhibiting glucan synthesis. They could be the foundation for a new group of antifungal agents, which 
affects a fungal cell wall, is safe, consisting of simple sugar structures, with hydrophilic properties. 
 These observations should be further explored as to the potential commercial value of cellobio-
oligosaccharides as fungal inhibitors, as well as additional products to support biofuel production from 
lignocelluloces. 
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